{"title":"Vaccines: RSV Vaccines, Flu Vaccines, Shingrix Vaccine, Hepatitis A \u0026 B Vaccines","description":"\u003ch1\u003eVaccines\u003c\/h1\u003e\n\u003cp\u003eVaccines are biological preparations that \u003cstrong\u003estimulate the immune system\u003c\/strong\u003e to protect against specific diseases. They work by introducing an antigen – a harmless or weakened fragment of a virus or bacterium (or sometimes just a key protein or piece of it) – so that the body’s immune system learns to recognize and fight that germ without causing illness. In other words, vaccines help your immune system build protection (through antibodies and immune “memory”) against a disease. As WHO explains, vaccines “reduce risks of getting a disease by working with your body’s natural defenses to build protection”. Importantly, because vaccines contain only killed or weakened germs (or parts of germs), they do \u003cstrong\u003enot\u003c\/strong\u003e cause the disease itself.\u003c\/p\u003e\n\u003ch1\u003eVaccine Types and How They Work\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eImmune training:\u003c\/strong\u003e Vaccines work by mimicking an infection – introducing a harmless form of a pathogen (weakened\/killed germs, a fragment of it, or even genetic instructions) to trigger the immune system. The immune system recognizes these vaccine antigens as foreign, produces antibodies and activates T-cells, and then retains “memory” of the pathogen. This immunologic memory means that if the real pathogen is encountered later, the body mounts a rapid, strong response and often prevents illness entirely.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eLive-attenuated vaccines:\u003c\/strong\u003e Use a weakened but live form of the germ (virus or bacterium). Because the pathogen can replicate a little, they closely mimic natural infection and induce a very strong, long-lasting immune response. Typically only one or two doses are needed for long-term protection. Examples: measles-mumps-rubella (MMR), varicella (chickenpox), and some oral polio and rotavirus vaccines. (These are very effective, but are usually avoided in people with severely weakened immunity.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eInactivated (killed) vaccines:\u003c\/strong\u003e Contain pathogens that have been killed or inactivated (e.g. by heat or chemicals) so they cannot replicate. They are very safe (even for immunocompromised people) but often produce a weaker immune response than live vaccines. To achieve and maintain immunity, multiple doses and periodic booster shots are usually required. Examples: injectable polio vaccine (IPV), hepatitis A vaccine, many flu shots, and rabies vaccine.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSubunit\/recombinant\/polysaccharide\/conjugate vaccines:\u003c\/strong\u003e Include only specific pieces of the pathogen (such as proteins, sugars, or capsid fragments) rather than the whole germ. By focusing the immune response on key antigens, they are very targeted and safe (suitable for most people, including those with weak immune systems). Often an adjuvant is added to boost immunity. Examples: hepatitis B and HPV vaccines use purified viral protein (recombinant subunits); the Hib and pneumococcal vaccines use bacterial polysaccharide capsules attached to a protein carrier (conjugates). These vaccines may require booster doses because only pieces of the germ are delivered.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eToxoid vaccines:\u003c\/strong\u003e Contain inactivated bacterial toxins (toxoids) instead of whole bacteria. The immune response is thereby directed against the toxin. Classic examples are tetanus and diphtheria vaccines, where immunity is generated against the harmful toxin produced by the bacteria rather than the bacteria themselves.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eViral vector vaccines:\u003c\/strong\u003e Use a harmless “carrier” virus (vector) that has been genetically engineered to carry a gene (or genes) from the target pathogen. Once injected, the vector infects cells and delivers the gene, causing the cells to produce the pathogen’s antigen (e.g. a viral protein). The immune system then responds to this antigen as if it were a real infection. This approach elicits a strong response akin to a live infection. Examples: some Ebola vaccines and COVID-19 vaccines (e.g. Johnson \u0026amp; Johnson, AstraZeneca) use adenovirus vectors to deliver SARS-CoV-2 spike protein genes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003emRNA vaccines:\u003c\/strong\u003e Contain messenger RNA (mRNA) encoding a pathogen antigen (usually packaged in a lipid nanoparticle). After injection, muscle cells take up the mRNA and use it to make the viral protein antigen. The immune system then recognizes this protein as foreign and generates antibodies and T-cells against it. This technology was used in the Pfizer-BioNTech and Moderna COVID-19 vaccines. mRNA vaccines do \u003cem\u003enot\u003c\/em\u003e contain live virus and do not alter human DNA. (A related approach uses DNA vaccines—still largely experimental—which deliver genetic instructions via a plasmid to produce antigens.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEach vaccine type is designed to present antigen(s) in a way that safely stimulates immunity. All approved vaccines have been shown to be safe and effective: they train our immune memory without causing the actual disease, protecting us (and indirectly our communities) from serious infections.\u003c\/p\u003e\n\u003ch2\u003eImpact and Importance\u003c\/h2\u003e\n\u003cp\u003eVaccination is one of the most effective public health interventions ever developed. According to WHO, “we now have vaccines to prevent more than 30 life-threatening diseases” and immunization \u003cstrong\u003e“prevents 3.5 million to 5 million deaths every year”\u003c\/strong\u003e from illnesses like diphtheria, tetanus, whooping cough, influenza, and measles. Widespread use of vaccines has led to the complete eradication of smallpox and the near-elimination of naturally occurring polio worldwide. By reaching high vaccination coverage, communities not only protect the vaccinated individuals but also reduce disease spread (known as \u003cstrong\u003eherd immunity\u003c\/strong\u003e), safeguarding people who cannot be vaccinated.\u003c\/p\u003e\n\u003cp\u003eBecause of these benefits, experts consider immunization one of the best health investments. WHO calls it “one of the best health investments money can buy”. Vaccines not only save individual lives but also prevent healthcare costs and economic losses from outbreaks. They are essential for controlling epidemics and pandemics; for example, routine vaccination campaigns are a key reason why diseases like measles and polio have nearly disappeared in many countries. In short, vaccines underpin global health security and are a vital tool in public health.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey Points:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eVaccines safely \u003cstrong\u003etrain the immune system\u003c\/strong\u003e to recognize and fight specific germs without causing the actual disease.\u003c\/li\u003e\n\u003cli\u003eThere are vaccines for \u003cem\u003edozens\u003c\/em\u003e of serious illnesses: WHO notes we have vaccines against more than 30 life-threatening diseases (e.g. measles, polio, HPV, influenza, hepatitis, etc.).\u003c\/li\u003e\n\u003cli\u003eImmunization saves millions of lives each year. WHO estimates that 3.5–5 million deaths are averted annually thanks to vaccination programs.\u003c\/li\u003e\n\u003cli\u003eVaccination is a highly cost-effective public health measure – WHO describes it as a top “health investment” – and it is critical for controlling outbreaks and protecting entire communities.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003eRSV Vaccines (Respiratory Syncytial Virus)\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNew RSV vaccines (2023)\u003c\/strong\u003e are recommended for adults and pregnant women. ACIP now advises \u003cstrong\u003eone dose of an RSV prefusion-protein vaccine\u003c\/strong\u003e for older adults: e.g. \u003cstrong\u003eArexvy\u003c\/strong\u003e (GSK) or \u003cstrong\u003eAbrysvo\u003c\/strong\u003e (Pfizer), and \u003cstrong\u003emRNA-1345 (mResVIA, Moderna)\u003c\/strong\u003e, for adults \u003cstrong\u003e≥60 years\u003c\/strong\u003e (recently updated to \u003cem\u003eall\u003c\/em\u003e ≥75 years and 60–74 at increased risk). Vaccination should be seasonal (fall\/winter) before RSV season. Those who already received an RSV vaccine do not need another dose.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaternal immunization:\u003c\/strong\u003e A single dose of Pfizer’s RSVpreF (Abrysvo) is recommended for pregnant persons \u003cstrong\u003eat 32–36 weeks’ gestation\u003c\/strong\u003e during RSV season. This protects infants (via placental antibodies) through the first 6 months of life, who otherwise would be at high risk of severe RSV. (If not given in pregnancy, Abrysvo can be given postpartum.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfants\/children:\u003c\/strong\u003e No active vaccine is yet approved for infants, but passive immunoprophylaxis is used. The monoclonal antibodies \u003cstrong\u003enirsevimab\u003c\/strong\u003e (recently FDA-approved) given to infants in RSV season, and \u003cstrong\u003epalivizumab\u003c\/strong\u003e (older product) for high-risk infants, can prevent severe RSV disease. These are not “vaccines” but provide immediate passive immunity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSummary:\u003c\/strong\u003e RSV vaccines are newly available. All at-risk older adults and pregnant women in RSV season should get the appropriate RSV vaccine dose. (Efficacy in trials was high: e.g. 94% protective efficacy of maternal vaccine against infant RSV hospitalization.)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003eInfluenza (“Flu”) Vaccines\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnnual recommendation:\u003c\/strong\u003e CDC\/ACIP recommend \u003cstrong\u003eeverybody age ≥6 months\u003c\/strong\u003e get an influenza vaccine \u003cstrong\u003eevery year\u003c\/strong\u003e. Ideally vaccinate in early fall (Sept\/Oct) so immunity is highest during peak flu season. However, vaccination is beneficial as long as flu viruses circulate (often through spring). Young children may need two doses the first year they are vaccinated (≥4 weeks apart).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVaccine types:\u003c\/strong\u003e Most flu shots are \u003cstrong\u003einactivated (killed)\u003c\/strong\u003e vaccines given intramuscularly. There are standard-dose egg-based vaccines (approved for 6+ months) and \u003cstrong\u003ecell-based or recombinant (egg-free)\u003c\/strong\u003e versions. There are also a live-attenuated nasal spray vaccine (approved for ages 2–49 years, non-pregnant). Formulations may be \u003cstrong\u003equadrivalent\u003c\/strong\u003e (covering two A strains and two B strains) or currently \u003cstrong\u003etrivalent\u003c\/strong\u003e (no B\/Yamagata circulating).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSpecial formulations:\u003c\/strong\u003e For older adults (≥65 years), \u003cstrong\u003ehigh-dose, adjuvanted, or recombinant formulations\u003c\/strong\u003e are FDA-approved and \u003cstrong\u003epreferentially recommended\u003c\/strong\u003e because they elicit stronger immunity in the elderly. (Examples: Fluzone® High-Dose, Flublok® recombinant, Fluad® adjuvanted.) Otherwise, no brand preference for younger persons – any age-appropriate vaccine should be used. People with egg allergies may receive any flu vaccine without special precautions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e The specific A\/B strains in the vaccine are updated yearly by FDA advisory committee based on surveillance. For example, the 2023–24 vaccine updated its A(H1N1)pdm09 component. Even if not a perfect match, flu vaccination reduces severity of illness and complications in vaccinated people.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003eShingrix – Recombinant Zoster Vaccine\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndication:\u003c\/strong\u003e Shingrix is a recombinant zoster vaccine (RZV) for \u003cstrong\u003eprevention of shingles (herpes zoster)\u003c\/strong\u003e and post-herpetic neuralgia. CDC recommends \u003cstrong\u003etwo doses of Shingrix for all adults ≥50 years\u003c\/strong\u003e, regardless of prior chickenpox or Zostavax history. Immunocompromised adults (19+ years) should also receive 2 doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e The two doses are given intramuscularly, with the second dose 2–6 months after the first. (If more than 6 months elapses, give the second dose as soon as possible; no need to restart.). If a patient had shingles, wait until recovery before vaccinating, but otherwise there is no need to screen for history of chickenpox.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVaccine details:\u003c\/strong\u003e Shingrix contains glycoprotein E antigen plus a potent adjuvant. In trials it showed \u0026gt;90% efficacy even in older age groups. It replaced the older live vaccine Zostavax (which is no longer used). Shingrix can be given at the same visit as other adult vaccines (e.g. flu, COVID-19) at different sites. Common side effects (pain, redness at injection site, fatigue) are usually mild-confirm or cite.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSpecial:\u003c\/strong\u003e No contraindications except known severe allergy to vaccine components. Immunization is highly encouraged even if the patient received Zostavax years ago (two doses of Shingrix are still recommended).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003eHepatitis A (HepA) Vaccine\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndication:\u003c\/strong\u003e Hepatitis A vaccine (inactivated HAV vaccine) is recommended for \u003cstrong\u003eall children\u003c\/strong\u003e (routine, first dose at age 12–23 months). Catch-up 2-dose vaccination is advised for any child or adolescent (2–18 years) who wasn’t previously immunized. Adults at high risk for HAV (e.g. travelers to endemic countries, men who have sex with men, people who use injection drugs, persons with chronic liver disease, clotting-factor disorders) should be vaccinated. CDC also says “any adult seeking protection” without specified risk should be offered the vaccine.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e The HepA vaccine is given in a 2-dose series (e.g. Havrix or Vaqta) separated by 6–18 months. (Some combination vaccines include HepA+HepB in multiple doses.) Full immunity develops about 1–2 weeks after the second dose. HepA vaccine provides long-term protection (decades). It can also be given as post-exposure prophylaxis (ideally within 2 weeks of exposure) along with immune globulin in some cases, per guidelines (beyond this summary).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Both doses are intramuscular. In children, the first dose is usually at 12–15 months and the second at 18–24 months. Adolescents receive 2 doses at least 6 months apart. Traveler guidelines: if an adult needs rapid protection before travel, accelerated schedules exist (two doses ≥6 months apart; sometimes combined with immune globulin).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch1\u003eHepatitis B (HepB) Vaccine\u003c\/h1\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndication:\u003c\/strong\u003e Hepatitis B vaccine (recombinant HBsAg) is \u003cstrong\u003euniversally recommended\u003c\/strong\u003e. All \u003cstrong\u003einfants\u003c\/strong\u003e should receive a birth dose (within 24 hours of birth) followed by 2 or 3 additional doses in the first year of life. It’s also recommended for any child or teen (\u0026lt;19 years) who missed infancy doses. \u003cstrong\u003eAdults\u003c\/strong\u003e up to age 59 should receive HepB vaccine routinely. Adults ≥60 with risk factors (healthcare work, dialysis, chronic liver disease, frequent blood exposure, multiple sex partners, etc.) or any adult who simply wants vaccination should also be immunized.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e The usual HepB series is \u003cstrong\u003e3 doses\u003c\/strong\u003e: typically at 0, 1, and 6 months (with some brand variations). For example, Engerix-B and Recombivax are 3-dose vaccines for ages ≥20. However, a newer adult HepB vaccine (Heplisav-B) is a \u003cstrong\u003e2-dose series (0,1 month)\u003c\/strong\u003e for patients 18+. Combination vaccines (Twinrix) also exist (HepA+HepB) in 3-4 doses for 18+. Infants get the pediatric formulation on a similar 3-shot schedule. High-risk adults (dialysis patients) may need an enhanced schedule (4 doses or higher dose).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e All HepB vaccines are intramuscular (preferred in the deltoid). Post-vaccine testing is optional except for certain occupations (like healthcare). HepB vaccination is safe in pregnancy and should not be deferred. (Pregnant women with risk factors are usually tested; if susceptible, they should be vaccinated.) Successive doses from different manufacturers are allowed if needed. A completed HepB series produces long-lasting, likely lifelong, immunity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCombination:\u003c\/strong\u003e One combined HepA-HepB vaccine (Twinrix) is licensed for adults 18+ (3-dose or accelerated 4-dose schedules) for those needing protection against both viruses. This can be used per labeling if indicated.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSummary:\u003c\/strong\u003e These vaccines protect against their respective pathogen. RSV vaccines (GSK, Pfizer, etc.) are newly available to protect older adults and infants (via maternal immunization) from severe RSV. Annual flu vaccines are advised for everyone \u0026gt;6 months, with updated strains each year. Shingrix (recombinant zoster) is an adjuvanted 2-dose vaccine for preventing shingles in adults 50+. Hepatitis A vaccine (2 doses) is given to young children routinely and to at-risk adults. Hepatitis B vaccine (usually 3 doses) is given universally starting at birth and recommended for all adults under 60 (and high-risk older adults). Follow the published schedules and storage guidelines for each vaccine.\u003c\/p\u003e\n\u003ch1\u003eMMR Vaccine\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003eMMR\u003c\/strong\u003e (Measles–Mumps–Rubella) vaccine is a \u003cstrong\u003elive, attenuated virus\u003c\/strong\u003e vaccine given subcutaneously. It protects against measles (rubeola), mumps, and rubella. The routine schedule is \u003cstrong\u003e2 doses\u003c\/strong\u003e: first at 12–15 months of age and second at 4–6 years of age. If a child misses this window, catch-up vaccination ensures a total of 2 doses (at least 28 days apart). One dose at ≥12 months provides ~93% protection against measles, and two doses are recommended to ensure long-term immunity. Adolescents and adults who lack documented immunity (no prior vaccination or infection) should receive at least one dose (two doses for certain groups like healthcare workers or during outbreaks). A combination MMRV (also containing varicella) is licensed for children 1–12 years as an alternative.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eContraindications\/Precautions:\u003c\/strong\u003e Because it is live, \u003cstrong\u003edo not give MMR to anyone who is pregnant or severely immunocompromised\u003c\/strong\u003e. Women of childbearing age should avoid pregnancy for one month after receiving MMR. Pregnant women with no evidence of rubella immunity should wait until after delivery to be immunized. Persons with a history of severe allergic reaction to neomycin, gelatin, or previous MMR dose should not receive it. (Minor illness without fever is not a contraindication.)\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration and Safety:\u003c\/strong\u003e MMR is injected subcutaneously (usually in the outer triceps area). Side effects are generally mild (fever, mild rash, swollen glands ~7–12 days post-vaccination); severe allergic reactions are very rare. Local soreness is uncommon since it’s subcutaneous; systemic reactions (fever, rash) occur in ~5–15% of vaccinees. In outbreaks or before international travel, an early dose at 6–11 months may be given, but it does not count toward the 2-dose series (those children still need 2 more doses after age 12 months).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey Point:\u003c\/strong\u003e Two doses of MMR are highly effective in preventing these three diseases. Universal childhood vaccination and catch-ups in older children\/adults maintain community protection. Keep MMR status up-to-date for healthcare workers, students, and travelers.\u003c\/p\u003e\n\u003ch1\u003eTdap Vaccine\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003eTdap\u003c\/strong\u003e is the \u003cstrong\u003eTetanus toxoid, reduced Diphtheria toxoid, and acellular Pertussis\u003c\/strong\u003e vaccine (brand names: Adacel®, Boostrix®). It is a \u003cstrong\u003ebooster\u003c\/strong\u003e vaccine containing the pertussis component (whereas Td has no pertussis). Tdap is given \u003cstrong\u003eintramuscularly\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eChildren\/Adolescents:\u003c\/strong\u003e After the 5-dose pediatric DTaP series (last dose at age 4–6), a single dose of Tdap is recommended at \u003cstrong\u003e11–12 years of age\u003c\/strong\u003e. This boosts tetanus\/diphtheria immunity and provides additional pertussis protection before adulthood. (If missed, give Tdap whenever feasible.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePregnancy:\u003c\/strong\u003e One Tdap dose is recommended during \u003cem\u003eeach pregnancy\u003c\/em\u003e, optimally between 27–36 weeks’ gestation. This maximizes antibody transfer to the infant, protecting newborns from pertussis (who are too young for their own vaccine). If not given during pregnancy, Tdap should be given immediately postpartum if the mother never had it.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAdults:\u003c\/strong\u003e Everyone ≥19 years old should have at least \u003cstrong\u003eone lifetime Tdap\u003c\/strong\u003e if not already received (the childhood Tdap covers teens). After that, Td boosters are given every 10 years; however, any one of these boosters can be Tdap if pertussis protection is desired. For example, healthcare providers or others in contact with infants typically get Tdap once and then Td thereafter. ACIP specifically recommends a single adult Tdap for anyone who missed it as a teen. (Boostrix is licensed for 65+, Adacel through age 64; either may be used in older adults if available.)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWound Prophylaxis:\u003c\/strong\u003e If a patient with a tetanus-prone wound has not had a booster in ≥5 years, a Tdap (or Td) booster is indicated as part of wound care.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eKey Points:\u003c\/strong\u003e Tdap is used once in adolescence and once each pregnancy (with Td boosters every 10 years). It protects against a pertussis outbreak in families and provides continued tetanus\/diphtheria immunity. Tdap should be given with standard injection technique (IM in the deltoid), and local soreness or minor systemic reactions (malaise, headache) can occur but serious side effects are uncommon.\u003c\/p\u003e","products":[{"product_id":"gardasil-9-vials-hpv-vaccine-10-pack","title":"Gardasil 9 Human Papillomavirus Vaccine (HPV vaccine) Recombinant, 20 mcg - 60 mcg (10-Pack) **Requires Refrigeration (RX)","description":"\u003cp\u003eGardasil 9 is a Human Papillomavirus (HPV) vaccine used to protect against cancers caused by HPV, including cervical, anal, and throat cancers, as well as genital warts. It offers protection against nine HPV types, significantly reducing the risk of infection. Administered through a series of injections, this vaccine plays a crucial role in preventive healthcare. It is effective in promoting immune protection and enhancing overall public health by reducing HPV-related disease prevalence.\u003c\/p\u003e\n\u003cp\u003eGardasil 9 is a leading vaccine designed to provide robust protection against certain strains of Human Papillomavirus (HPV). Manufactured by Merck, this recombinant vaccine targets nine HPV types—6, 11, 16, 18, 31, 33, 45, 52, and 58—responsible for the majority of HPV-related cancers and diseases. With its advanced formulation, Gardasil 9 empowers individuals to safeguard their health and reduce the risk of developing HPV-related cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as genital warts.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Strengths:\u003c\/strong\u003e Offers antigen levels ranging from 20 mcg to 60 mcg, tailored to confer optimal immunity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Protection:\u003c\/strong\u003e Covers nine HPV types responsible for approximately 90% of cervical cancer cases.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTarget Audience:\u003c\/strong\u003e Approved for use in both males and females, typically starting from ages 9 to 45.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Recombinant vaccine, meaning it uses a safe, non-infectious virus-like particle (VLP) to elicit an immune response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Administered via intramuscular injection, typically in a series of two or three doses depending on the age and health status of the recipient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGardasil 9 works by introducing non-infectious VLPs resembling the HPV virus to the body. This prompts the immune system to produce antibodies, equipping the body to recognize and neutralize the actual virus if exposed in the future. The vaccine does not contain live virus, ensuring safety while effectively stimulating a protective immune response.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eVaccination Schedule:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAges 9-14:\u003c\/strong\u003e Two doses, with a second dose given 6-12 months after the first.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAges 15-45 and Immunocompromised Individuals:\u003c\/strong\u003e Three doses, with the second and third doses given two and six months after the first, respectively.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRoute of Administration:\u003c\/strong\u003e Administered intramuscularly, typically in the upper arm or thigh.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergic Reactions:\u003c\/strong\u003e Immediate medical attention is required for severe allergic reactions, such as difficulty breathing, wheezing, hives, or swelling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Breastfeeding:\u003c\/strong\u003e Not recommended for pregnant women; if pregnancy is discovered post-vaccination, notify your healthcare provider. Consult a doctor before receiving the vaccine while breastfeeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSyncope (Fainting):\u003c\/strong\u003e Patients should be observed for at least 15 minutes post-vaccination to manage any immediate adverse reactions, including fainting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInjection-site reactions: Pain, swelling, or redness\u003c\/li\u003e\n\u003cli\u003eHeadache\u003c\/li\u003e\n\u003cli\u003eFever\u003c\/li\u003e\n\u003cli\u003eNausea\u003c\/li\u003e\n\u003cli\u003eDizziness\u003c\/li\u003e\n\u003cli\u003eFatigue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost side effects are mild and resolve on their own. Contact your healthcare provider if you experience persistent or severe symptoms.\u003c\/p\u003e\n\u003cp\u003eGardasil 9 is a pivotal tool in the prevention of HPV-related diseases. Consult your healthcare provider to learn if Gardasil 9 is appropriate for you or your loved ones, and take proactive steps to protect against HPV.\u003c\/p\u003e","brand":"Merck","offers":[{"title":"Default Title","offer_id":12099154575432,"sku":"00006-4121-02","price":4200.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Gardasil-9-Human-Papillomavirus-Vaccine-Syringes.jpg?v=1742574664"},{"product_id":"mmr-vacccine-measles-mumps-and-rubella-virus-vaccine-10-doses","title":"MMR Vaccine for Measles, Mumps \u0026 Rubella Virus 10 Doses (Rx) *Refrigerated","description":"\u003ch3\u003e\u003cstrong\u003eComplete Protection Against Measles, Mumps, and Rubella In One Shot\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eProtect your family and your community from highly contagious diseases with the MMR Vaccine for Measles, Mumps \u0026amp; Rubella (10 Dose Vial) by Merck \u0026amp; Co—the gold standard solution for long-lasting immunity against three of the world’s most serious viral infections.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePlease note: \u003cspan style=\"color: rgb(203, 54, 54);\"\u003eSpecial Order, Cannot Be Cancelled Once Order Is Placed\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003eWhat is the MMR Vaccine?\u003c\/h3\u003e\n\u003cp\u003eThe \u003cstrong\u003eMMR vaccine\u003c\/strong\u003e is a highly effective and safe immunization that \u003cstrong\u003eprotects against three viral diseases\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMeasles (rubeola): A highly contagious airborne virus causing high fever, cough, and rash and can lead to severe complications\u003c\/li\u003e\n\u003cli\u003eMumps: Causes fever, headache, swollen glands, and can result in complications such as meningitis or infertility\u003c\/li\u003e\n\u003cli\u003eRubella (German measles): Mild in children but dangerous for pregnant women, causing birth defects and complications\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe MMR vaccine uses \u003cstrong\u003elive attenuated viruses\u003c\/strong\u003e to safely stimulate the body’s immune system, building powerful, long-term protection.\u003c\/p\u003e\n\u003ch3\u003eTop Features \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive 3-in-1 Protection\u003c\/strong\u003e: Defend against measles, mumps, AND rubella with 1 vaccine\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBulk 10 Dose Vial\u003c\/strong\u003e: Ideal for clinics, schools, hospitals, and immunization campaigns\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCDC \u0026amp; WHO Recommended\u003c\/strong\u003e: Meets global immunization guidelines for children and adults\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEasy Administration\u003c\/strong\u003e: Subcutaneous injection, simple for healthcare providers\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSafe and Proven\u003c\/strong\u003e: Manufactured by \u003cstrong\u003eMerck \u0026amp; Co\u003c\/strong\u003e, a leader in vaccine innovation and safety\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eMMR Vaccine Schedule \u0026amp; Dosage\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eFor Children:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFirst Dose:\u003c\/strong\u003e 12–15 months of age\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSecond Dose:\u003c\/strong\u003e 4–6 years of age (before entering school)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMinimum Interval:\u003c\/strong\u003e 28 days between two doses\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eFor Adults:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdults born after 1957 without evidence of immunity should receive at least one dose\u003c\/li\u003e\n\u003cli\u003eSome adults (healthcare workers, international travelers, college students) may require two doses, at least 28 days apart\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEach dose: \u003cstrong\u003e0.5 mL\u003c\/strong\u003e, administered by subcutaneous injection, typically in the upper arm\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eHow is the MMR Vaccine Administered?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eInject \u003cstrong\u003e0.5 mL\u003c\/strong\u003e of the reconstituted vaccine subcutaneously\u003c\/li\u003e\n\u003cli\u003eFor children, the thigh or arm is preferred; for adults, the upper arm\u003c\/li\u003e\n\u003cli\u003eSafe for co-administration with other routine vaccines (e.g., Varicella, Hepatitis, DTaP)\u003c\/li\u003e\n\u003cli\u003eClinic or hospital setting recommended for proper storage and administration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWHO Needs the MMR Vaccine?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAll children\u003c\/strong\u003e following routine vaccine schedule\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnvaccinated adults\u003c\/strong\u003e at risk of exposure\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eInternational travelers\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHealthcare and school personnel\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWomen of childbearing age\u003c\/strong\u003e (ensure not pregnant when vaccinated)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eMMR Vaccine Side Effects \u0026amp; Safety Information\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eMost people have no serious side effects. Rarely, symptoms may include:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSoreness, redness, or swelling at injection site\u003c\/li\u003e\n\u003cli\u003eFever\u003c\/li\u003e\n\u003cli\u003eMild rash\u003c\/li\u003e\n\u003cli\u003eTemporary joint pain (mainly in adults)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRare but Serious Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAllergic reaction (hives, difficulty breathing)\u003c\/li\u003e\n\u003cli\u003eSeizures (due to fever)\u003c\/li\u003e\n\u003cli\u003eTemporary low platelet count\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWho should NOT receive MMR vaccine?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePregnant women\u003c\/li\u003e\n\u003cli\u003eSeverely immunocompromised patients\u003c\/li\u003e\n\u003cli\u003ePersons with severe allergy to vaccine components (neomycin or gelatin)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eAlways consult your healthcare provider to ensure the MMR vaccine is right for you or your child.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTags:\u003c\/strong\u003e \u003cspan class=\"VODHU pdMy8\"\u003eMMR vaccine, measles mumps rubella vaccine, children immunization, adult vaccination, MMR vaccine schedule, measles vaccine, mumps vaccine, rubella vaccine, childhood vaccinations, CDC recommended vaccines, immunization schedule, MMR vaccine side effects, vaccine for school entry, international travel vaccines, Merck MMR vaccine, 10 dose MMR vial, what is MMR vaccine, vaccine dosage for kids, vaccine dosage for adults, best vaccines for measles, buy MMR vaccine online.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eWhy Choose the MMR Vaccine by Merck \u0026amp; Co?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eProven Efficacy:\u003c\/strong\u003e Over 95% protection after two doses\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Worldwide:\u003c\/strong\u003e Millions immunized globally\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCost-Effective 10 Dose Vial:\u003c\/strong\u003e Perfect for high-volume clinics and health programs\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMeets All International Travel \u0026amp; School Requirements\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eOrder the MMR Vaccine for Measles, Mumps \u0026amp; Rubella Virus (10 Dose Vial) by Merck \u0026amp; Co Today!\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eIn Stock \u0026amp; Ready to Ship\u003c\/li\u003e\n\u003cli\u003eIdeal for Clinics, Hospitals \u0026amp; School Immunization Programs\u003c\/li\u003e\n\u003cli\u003eProtect against outbreaks and keep your community safe\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePrepare for a healthier future—choose the MMR vaccine by Merck \u0026amp; Co, your reliable defense against measles, mumps, and rubella!\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan class=\"VODHU pdMy8\"\u003eDon’t wait—ensure lifelong protection for your family or patients. Buy the MMR 10 Dose Vaccine by Merck \u0026amp; Co now!\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"Merck \u0026 Co","offers":[{"title":"Default Title","offer_id":12099157819464,"sku":"00006-4681-00","price":1449.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/MMR-Vaccine-for-Measles_-Mumps-Rubella-Virus-10-Doses.jpg?v=1758573732"},{"product_id":"rabavert-rabies-vaccine-kit","title":"Rabavert Rabies Vaccine Single-Dose Indicated for All Age Groups **Refrigerated Product","description":"Rabavert Rabies Vaccine Single-Dose Indicated for All Age Groups is a safe and effective distribution method for the vaccination against serious and preventable rabies virus. This single-dose vaccine is approved by the Food and Drug Administration as indicated for all age groups from 3 months and older and is the first rabies vaccine designed for more extended protection against the virus. This omni-age approved vaccination methodology is presented with diversified safety profile and assessment of antibodies levels after one dose making it the most convenient and viable distribution method used for rabies definition today, achieving up to five years of post-immunization protection in adults. Given its high safety profile and extended performance, this innovative vaccination method underscores its role in protecting millions of people around the world from this deadly virus.","brand":"Bavarin Nordic inc","offers":[{"title":"Default Title","offer_id":12105360605256,"sku":"50632-0010-01","price":695.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Rabavert-Rabies-Vaccine-Single-Dose-Indicated-for-All-Age-Groups.jpg?v=1691423933"},{"product_id":"shingrix-shingles-vaccine-20-vials","title":"Shingrix (Zoster Vaccine Recombinant, Adjuvanted) Suspension 50 mcg\/0.5 mL Single Dose Vial, 10 Pack **Refrigerated Item**","description":"SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) Suspension 50 mcg\/0.5 mL Single Dose Vial, 10 Pack. Shingrix Shingles Vaccine is an intramuscular injection used to prevention of herpes zoster (shingles) in adults aged 50 years and older.\u003cbr\u003e\u003cbr\u003eSHINGRIX is a suspension for injection supplied as a single-dose vial of lyophilized gE antigen component to be reconstituted with the accompanying vial of AS01B adjuvant suspension component.\u003cbr\u003eA single dose after reconstitution is 0.5mL.\u003cbr\u003e\u003cbr\u003eSHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) is a sterile\u003cbr\u003esuspension for intramuscular injection. The vaccine is supplied as a vial oflyophilized recombinant varicella zoster virus surface glycoprotein E (gE) antigen component,which must bereconstituted at the time of use\u003cbr\u003ewith the accompanying vial of AS01Badjuvantsuspensioncomponent.The lyophilizedge antigen component is presented in the form of a sterile white powder.The AS01Badjuvant suspension component is an opalescent, colorless to pale brownish liquid\u003cbr\u003esupplied in vials. The gE antigen is obtained by culturing genetically engineered Chinese Hamster Ovary cells, which carry a truncated gE gene, inmedia containing amino acids, with no albumin,\u003cbr\u003eantibiotics, or animal-derived proteins.The gE protein is purified by several chromatographic steps, formulated with excipients, filled into vials,and lyophilized.The adjuvant suspension componentis AS01\u003cbr\u003eB which is composed of 3-O-desacyl-4’-monophosphoryl lipid A (MPL) from Salmonella Minnesota and QS21,a saponinpurified fromplant extract Quillaja saponaria Molina,combinedin a liposomal formulation. The liposomes\u003cbr\u003eare composed of dioleoylphosphatidylcholine(DOPC)and cholesterol in phosphate-buffered saline solution containing disodium phosphateanhydrous, potassium dihydrogen phosphate, sodium chloride,\u003cbr\u003eand water for injection. After reconstitution, each 0.5-mL dose is formulated to contain 50mcg of the recombinant gEantigen, 50mcg of MPL,and 50mcg of QS-21.Each dose also contains 20\u003cbr\u003emg of sucrose(as stabilizer), 4.385mg of sodium chloride, 1mg of DOPC, 0.5mg of potassium dihydrogen phosphate, 0.25mg of cholesterol, 0.160of sodium dihydrogen phosphate dihydrate, 0.15mg of\u003cbr\u003edisodium phosphate anhydrous, 0.116\u003cbr\u003emg of dipotassium phosphate,and 0.08mg of polysorbate 80.After reconstitution, SHINGRIX is a sterile,opalescent, colorless to pale brownish liquid.SHINGRIX does not contain preservatives.Each dose may also contain residual amounts of host\u003cbr\u003ecell proteins (≤3.0%) and DNA (≤2.1 picograms) from the manufacturing process. The vial stoppers are not made with natural rubber latex.\u003cbr\u003e\u003cbr\u003eBrand: GlaxoSmithKline\u003cbr\u003e\u003cbr\u003eSize: 10 Vials\u003cbr\u003e\u003cbr\u003eNDC: 58160-0823-11\u003cbr\u003e\u003cbr\u003eUPC: 581600823119\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eBuy Shingrix Shingles Vaccine, 20 Vials online at Mountainside Medical Equipment.","brand":"GSK Vaccines","offers":[{"title":"Default Title","offer_id":12105366143048,"sku":"58160-0823-11","price":2455.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Shingrix-Shingles-Vaccine-20-Vials-Bulk-Pack.jpg?v=1600379374"},{"product_id":"tubersol-tuberculin-purified-protein-derivative-mantoux-1-ml-10-tests","title":"Tubersol Tuberculin Purified Protein Derivative 1 mL (10 Tests) (Rx) *Refrigerated","description":"\u003ch1\u003eTubersol Tuberculin Purified Protein Derivative\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003eTubersol\u003c\/strong\u003e by \u003cstrong\u003eSanofi\u003c\/strong\u003e is the gold standard for accurate, reliable, and safe screening of latent and active tuberculosis (TB) infection. This FDA-approved, sterile, Tween-stabilized \u003cstrong\u003eTuberculin Purified Protein Derivative (PPD)\u003c\/strong\u003e solution is preferred by clinics, hospitals, occupational health, and public health facilities for the \u003cstrong\u003eMantoux tuberculin skin test (TST)\u003c\/strong\u003e procedure. With rigorous manufacturing and globally trusted performance, Tubersol simplifies TB screening for healthcare professionals and ensures the best results for patient monitoring and outbreak control.\u003c\/p\u003e\n\u003cp\u003eTubersol Tuberculin Purified Protein Derivative (PPD) (Mantoux) 1 mL (10 Tests) Tween Stabilized Solution is the trusted choice for healthcare professionals worldwide in the detection of latent or active tuberculosis (TB) infection. This highly purified PPD solution is specifically designed for the renowned Mantoux tuberculin skin test (TST). Each vial contains 1 mL of stabilized solution (equal to 10 tests), ensuring consistency, accuracy, and reliability in TB screening programs for hospitals, laboratories, public health agencies, and clinics.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eHow Tubersol Works\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eTubersol is administered intradermally via the Mantoux technique. The purified protein derivative (PPD) stimulates a delayed-type hypersensitivity (DTH) immune response in individuals sensitized to Mycobacterium tuberculosis. Read the induration region at the site 48-72 hours post-injection for accurate TB diagnosis.\u003c\/p\u003e\n\u003cp\u003eTubersol Tuberculin Purified Protein Derivative (Mantoux) is used for conducting the Mantoux tuberculin skin test, which helps diagnose latent tuberculosis infection. This solution is administered intradermally to assess the body's immune response to the TB antigen. A critical tool in public health, it aids in identifying individuals who have been exposed to Mycobacterium tuberculosis. The solution is stabilized with Tween, ensuring consistent results for accurate TB screening and management.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eInterpretation of Results\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePositive TST:\u003c\/strong\u003e Indicates TB infection (active or latent); follow up with chest x-ray and\/or clinical assessment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNegative TST:\u003c\/strong\u003e Typically rules out TB infection; consider patient history, risk factors, and immunocompromised status.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFull Manufacturer’s Instructions Provided\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eTubersol Tuberculin Purified Protein Derivative (Mantoux) 1 mL\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eQuantity: \u003c\/strong\u003e10 Tests per vial\u003cbr\u003e\u003cstrong\u003eFormulation:\u003c\/strong\u003e Tween Stabilized Solution\u003cbr\u003e\u003cstrong\u003eMethod:\u003c\/strong\u003e Mantoux method – intradermal injection\u003cbr\u003e\u003cstrong\u003eIntended Use:\u003c\/strong\u003e Detection of latent tuberculosis infection\u003cbr\u003e\u003cstrong\u003eApplication:\u003c\/strong\u003e Used by healthcare professionals for skin test diagnosis\u003cbr\u003e\u003cstrong\u003eDosage and Administration:\u003c\/strong\u003e Follow healthcare guidelines for dosage and administration for conducting the Mantoux test\u003cbr\u003e\u003cstrong\u003eStorage Conditions:\u003c\/strong\u003e Store refrigerated between 2°C and 8°C (35°F to 46°F); do not freeze\u003cbr\u003e\u003cstrong\u003eStability:\u003c\/strong\u003e Ensure the solution is clear and free from particulate matter before use\u003cbr\u003e\u003cstrong\u003ePrecautions:\u003c\/strong\u003e For professional use only; read the package insert for full instructions and safety information before use\u003c\/p\u003e\n\u003ch2\u003eOrder Tubersol Tuberculin PPD (Mantoux) 1 mL (10 Tests) by Sanofi Today!\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eNDC:\u003c\/strong\u003e 49281-0752-21 | \u003cstrong\u003eUPC:\u003c\/strong\u003e 349281752216 \u003cstrong\u003eFast Shipping | 100% Authentic | Bulk Discounts Available\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnsure TB safety for your facility, workforce, or patient population with the leading tuberculin PPD test from Sanofi. For the best accuracy, reliability, and clinical value—choose Tubersol for your tuberculosis testing needs.\u003c\/p\u003e","brand":"Sanofi","offers":[{"title":"Default Title","offer_id":12242807357512,"sku":"49281-0752-21","price":249.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tubersol-Tuberculin-Purified-Protein-Derivative-Mantoux-10-tests-bySanofi-NDC-49281-0752-21.jpg?v=1721934988"},{"product_id":"tubersol-tuberculin-purified-protein-derivative-mantoux-5-ml-50-tests","title":"Tubersol Tuberculin Purified Protein Derivative (Mantoux) 5 mL (50 Tests) *Refrigerated*","description":"\u003cp\u003e\u003cstrong\u003eTubersol Tuberculin Purified Protein Derivative (Mantoux) 5 mL (50 Tests) by Sanofi – The Gold Standard for TB Diagnosis\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 10.5pt;\"\u003e\u003cstrong\u003e\u003cspan style=\"font-family: 'Segoe UI', sans-serif; color: #ff2a00;\"\u003e***Item Requires Refrigeration***\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eFast, Reliable Tuberculosis (TB) Testing for Healthcare Professionals\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eTubersol Tuberculin Purified Protein Derivative (Mantoux) 5 mL (50 Tests)\u003c\/strong\u003e by Sanofi is the industry-leading solution for efficient and highly accurate \u003cstrong\u003etuberculosis (TB) screening\u003c\/strong\u003e and \u003cstrong\u003ediagnostic testing\u003c\/strong\u003e. Trusted by \u003cstrong\u003ehospitals, clinics, physicians, public health programs\u003c\/strong\u003e, and occupational health settings worldwide, Tubersol enables fast, sensitive detection of \u003cem\u003eMycobacterium tuberculosis\u003c\/em\u003e infection, including latent tuberculosis infection (LTBI). This Mantoux test is your top choice for meeting CDC TB screening protocols and ensuring \u003cstrong\u003epatient safety\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2\u003eProduct Features \u0026amp; Benefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurified Protein Derivative (PPD):\u003c\/strong\u003e Standardized and FDA-approved for reliable Mantoux tuberculin skin tests.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Sensitivity \u0026amp; Specificity:\u003c\/strong\u003e Detects both latent and active TB infection with exceptional accuracy, reducing false positives and negatives.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEasy-to-Use 5 mL Vial:\u003c\/strong\u003e Each vial yields up to 50 tests, perfect for high-volume screening in healthcare settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLong Shelf Life:\u003c\/strong\u003e Maintains potency when properly stored, optimizing cost-efficiency and inventory management.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSanofi Quality:\u003c\/strong\u003e Manufactured to the highest pharmaceutical standards for safety and efficacy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv style=\"text-align: center;\"\u003e\u003cimg style=\"margin-right: autopx; margin-bottom: 16px; margin-left: autopx; float: none;\" alt=\"Doctor holding Tubersol Tuberculin Purified Protein Derivative (Mantoux) Vial\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Doctor-holding-Tubersol-Tuberculin-Purified-Protein-Derivative-_Mantoux_-Vial_480x480.jpg?v=1758631354\"\u003e\u003c\/div\u003e\n\u003ch2\u003eWhy Use Tubersol for Tuberculosis Testing?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevent TB Spread:\u003c\/strong\u003e Early detection is critical for TB control and public health.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMandatory for Healthcare Workers:\u003c\/strong\u003e Adheres to CDC, WHO, and OSHA regulations for employee health screening.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAccurate TB Diagnosis:\u003c\/strong\u003e Essential for screening at-risk populations, such as immunocompromised patients, HIV-positive individuals, and recent immigrants.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsistent Results:\u003c\/strong\u003e Gold standard for TB surveillance, pre-employment exams, and routine physicals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDirections for Use\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdminister Intradermally:\u003c\/strong\u003e Following CDC and manufacturer protocols, inject 0.1 mL intradermally on the forearm.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRead 48-72 Hours Later:\u003c\/strong\u003e Measure induration to determine TB infection status.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical Interpretation:\u003c\/strong\u003e Consult with public health or infectious disease guidelines.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2\u003eSpecifications:\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Sanofi\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVolume:\u003c\/strong\u003e 5 mL vial (50 tests)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Purified Protein Derivative (Mantoux)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUsage:\u003c\/strong\u003e For healthcare professional use only\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eOrder Tubersol Tuberculin Today\u003c\/h2\u003e\n\u003cp\u003eStay compliant, protect your patients and staff, and make \u003cstrong\u003eTubersol Tuberculin Purified Protein Derivative (Mantoux) 5 mL (50 Tests) by Sanofi\u003c\/strong\u003e your first choice for \u003cstrong\u003ereliable, large-scale TB screening\u003c\/strong\u003e. \u003cstrong\u003eOrder now\u003c\/strong\u003e for fast shipping and exceptional customer support.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eBuy Tubersol PPD now and safeguard your healthcare environment with the world’s leading TB testing solution!\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Sanofi","offers":[{"title":"Default Title","offer_id":12242808078408,"sku":"49281-0752-22","price":639.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tubersol-Tuberculin-Purified-Protein-Derivative-_Mantoux_-5-mL.jpg?v=1758631156"},{"product_id":"aplisol-tuberculin-purified-protein-derivative-mantoux-1-ml-10-tests","title":"Aplisol Tuberculin Purified Protein Derivative Skin Test Diluted 1 mL (10 Tests) (Rx) * Refrigerated Item *","description":"\u003cp\u003ePar Sterile Products Aplisol Tuberculin Purified Protein Derivative, specifically Diluted 1 mL (10 Tests), is used to perform the Mantoux tuberculin skin test for detecting latent tuberculosis (TB) infections. Administered intradermally, Aplisol triggers an immune response in individuals previously sensitized to Mycobacterium tuberculosis. Health professionals evaluate the injection site 48 to 72 hours later for any induration or swelling, which may indicate TB exposure. This test is crucial for screening vulnerable populations, aiding in early TB detection, monitoring, and potential treatment.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #ff2a00;\"\u003e\u003cstrong\u003e\u003cem\u003e*** Item ships next day air, signature required. ***\u003c\/em\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eAplisol Test is a simple modified complement fixation test used to detect Mycobacterium tuberculosis (MTB) antigens in human body. Aplisol Test (also known as Tuberculin Purified Protein Derivative or PPD) is made up of a solution and MTB germs which can attach to antibodies present in the person's body to form a foam when injected beneath the person's skin. If the person has been in contact with MTB, he\/she produces antibodies against MTB and so the Aplisol Test would check for this and it provides results in two days. In other words, Aplisol Test functions as an immunological reagent and detects antibody\/antigen reactions in people to test whether an individual is infected with or has been exposed to certain disease-causing bacteria. It is a highlyspecifi test which can beochecked for infections like Tuberculosis and so is most widely used Aplisol Test around the world.\u003cspan style=\"color: #ff2a00;\"\u003e\u003cstrong\u003e\u003cem\u003e\u003c\/em\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAplisol Tuberculin Purified Protein Derivative, Diluted\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Par Sterile Products LLC\u003cbr\u003e\u003cstrong\u003eVolume:\u003c\/strong\u003e 1 mL per vial (sufficient for 10 skin tests)\u003cbr\u003e\u003cstrong\u003eComposition:\u003c\/strong\u003e Purified protein derivative\u003cbr\u003e\u003cstrong\u003eIntended Use: \u003c\/strong\u003eDiagnostic aid for the detection of latent Mycobacterium tuberculosis infection using the Mantoux technique.\u003cbr\u003e\u003cstrong\u003eApplication Method: \u003c\/strong\u003eIntradermal injection following the Mantoux method\u003cbr\u003e\u003cstrong\u003eTarget Users: \u003c\/strong\u003eHealthcare professionals in medical settings\u003cbr\u003e\u003cstrong\u003eDosage: \u003c\/strong\u003eTypically 0.1 mL is injected intradermally for each test, as per healthcare guidelines\u003cbr\u003e\u003cstrong\u003eStorage Requirements: \u003c\/strong\u003eRefrigerate at 2°C to 8°C (35°F to 46°F); maintain proper cold chain until use\u003cbr\u003e\u003cstrong\u003eSafety Precautions:\u003c\/strong\u003e Strictly for healthcare professional use; consult the package insert for detailed instructions, guidelines, and safety precautions.\u003cbr\u003e\u003cstrong\u003eInspection: \u003c\/strong\u003eEnsure solution clarity and absence of particulates prior to use\u003cbr\u003e\u003cstrong\u003eRegulatory Compliance:\u003c\/strong\u003e Adheres to healthcare and safety standards for TB testing\u003c\/p\u003e\n\u003cp\u003eAplisol is an efficient, trusted choice for healthcare providers committed to excellence in TB testing and control, delivering consistent results to facilitate proactive health management.\u003cbr\u003e\u003c\/p\u003e\n\u003c!-- Microdata markup added by Google Structured Data Markup Helper. --\u003e","brand":"Par Sterile Products LLC","offers":[{"title":"Default Title","offer_id":12242823118920,"sku":"42023-0104-01","price":229.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tuberculin-Purified-Protein-Derivative-Diluted-Aplisol-1-mL-by-Par-Sterile-NDC-42023-0104-01.jpg?v=1722001522"},{"product_id":"aplisol-tuberculin-purified-protein-derivative-mantoux-5-ml-50-tests","title":"Aplisol Tuberculin TB Test PPD Purified Protein Derivative Mantoux Skin Test 5 TU \/0.1 mL 5 mL (50 Tests) (Rx) Refrigerated","description":"\u003ch1\u003eAplisol Tuberculin TB Skin Test (M\u003cspan class=\"VODHU pdMy8\"\u003eantoux Test)\u003c\/span\u003e\n\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eAplisol\u003c\/strong\u003e is a sterile intradermal diagnostic antigen used to detect \u003cem\u003eMycobacterium tuberculosis\u003c\/em\u003e infection. It contains \u003cstrong\u003epurified protein derivative (PPD)\u003c\/strong\u003e from \u003cem\u003eM. tuberculosis\u003c\/em\u003e (prepared by the Seibert method) at a standardized potency of \u003cstrong\u003e5 tuberculin units (TU) per 0.1 mL\u003c\/strong\u003e. Aplisol is indicated \u003cstrong\u003eas an aid\u003c\/strong\u003e in diagnosing tuberculosis infection (latent or active). It is not a vaccine or treatment, but a skin test antigen. The solution is ready-to-use (no dilution needed) and contains a phenol preservative\u003c\/span\u003e.\u003c\/p\u003e\n\u003ch2\u003eAplisol Tuberculin PPD Skin Test Features:\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHighest Accuracy for TB Testing:\u003c\/strong\u003e Contains purified protein derivative (PPD) with 5 Tuberculin Units (TU) per 0.1 mL for standard, CDC-recommended Mantoux tuberculin skin testing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA Approved \u0026amp; Clinician Trusted:\u003c\/strong\u003e Aplisol is manufactured under strict sterile conditions, ensuring safety and reliability for mass screening and routine testing purposes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBulk 5mL Vial – 50 Doses:\u003c\/strong\u003e Cost-effective, convenient packaging meets high-volume screening needs in healthcare, laboratory, and workplace environments.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterile, Non-Pyrogenic Solution:\u003c\/strong\u003e Reduces risk of patient reactions and provides consistent testing results.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid, Easy Administration:\u003c\/strong\u003e Administers easily with a single intradermal injection; results can be evaluated within 48 – 72 hours for fast, actionable TB detection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad Applications:\u003c\/strong\u003e Essential for entry\/annual screening of healthcare workers, students, correctional facilities, immigrants, and close contacts of TB patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eAdministration (Mantoux Method)\u003c\/h2\u003e\n\u003cp\u003eThe standard Mantoux technique is used with Aplisol. A trained healthcare provider performs the test as follows.\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eInject 0.1 mL intradermally (5 TU):\u003c\/strong\u003e Using a 27-gauge needle, inject 0.1 mL of Aplisol into the \u003cstrong\u003evolar (inner) surface of the forearm\u003c\/strong\u003e, about 4″ below the elbow. A small pale wheal (6–10 mm) should appear if done correctly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReading the site (48–72 hours):\u003c\/strong\u003e The injection site is examined \u003cstrong\u003e48 to 72 hours\u003c\/strong\u003e later by a trained reader. Measure only the diameter of \u003cstrong\u003einduration\u003c\/strong\u003e (the firm, raised area) in millimeters; do \u003cstrong\u003enot\u003c\/strong\u003e measure redness (erythema). If no induration is palpable, record “0 mm.” If only erythema (redness) is present without induration, the test is considered negative (often indicating too-deep injection). If an improper dose was given or the test invalid (no wheal), the test should be repeated at a new site..\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration tips:\u003c\/strong\u003e Use a new sterile syringe\/needle per patient and clean the site with alcohol before injection. Ensure the full 0.1 mL (5 TU) is delivered intradermally; more than 30 minutes elapsing before testing can reduce potency. Pregnancy is \u003cstrong\u003enot\u003c\/strong\u003e a contraindication; tuberculin testing is considered safe and valid during pregnancy.\u003c\/p\u003e\n\u003ch2\u003eInterpreting Results\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePositive reaction:\u003c\/strong\u003e An induration \u003cstrong\u003e≥5 mm\u003c\/strong\u003e is considered positive in \u003cem\u003ehigh-risk\u003c\/em\u003e individuals (e.g. HIV-positive, recent TB contacts, immunosuppressed). An induration \u003cstrong\u003e≥10 mm\u003c\/strong\u003e is positive in people with moderate risk (e.g. immigrants from high-TB countries, injection drug users, certain medical conditions, children \u0026lt;5). An induration \u003cstrong\u003e≥15 mm\u003c\/strong\u003e is positive in people with \u003cem\u003eno\u003c\/em\u003e known risk factors. (These cutoffs follow current CDC guidelines.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNegative reaction:\u003c\/strong\u003e An induration \u003cstrong\u003e\u0026lt;5 mm\u003c\/strong\u003e is typically negative in low-risk people. However, false negatives can occur in immunocompromised persons or very recent infections (it takes 2–8 weeks post-infection for a positive PPD to develop).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEach result must be interpreted in context. For example, a \u003cem\u003eBCG-vaccinated\u003c\/em\u003e person with a positive reaction should be evaluated as if \u003cem\u003enot\u003c\/em\u003e vaccinated (since BCG effects wane over time). Likewise, repeat “two-step” testing (two PPD tests 1–3 weeks apart) may be used in periodic screening to distinguish a boosted reaction from a new infection.\u003c\/p\u003e\n\u003ch2\u003eSide Effects and Reactions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eLocal reactions\u003c\/strong\u003e are common: pain, redness, swelling at injection site. A strongly positive test can cause blistering, ulceration, or necrosis at the site, sometimes leading to a scar. These are not infections but inflammatory responses. Apply cold packs or topical steroids for comfort if needed.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSystemic allergic reactions\u003c\/strong\u003e are very rare but possible: rash, urticaria, angioedema, and even anaphylaxis have been reported. If any sign of severe allergy occurs, seek medical help immediately. Note: because of the preservative phenol, some people may have mild sensitivity.\u003c\/p\u003e\n\u003ch2\u003eProduct Specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBrand:\u003c\/strong\u003e Aplisol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Par Sterile Products LLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eType:\u003c\/strong\u003e Tuberculin PPD Purified Protein Derivative\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration:\u003c\/strong\u003e 5 TU \/ 0.1 mL (standard Mantoux test)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVial Size:\u003c\/strong\u003e 5 mL multi-dose vial (approx. 50 tests\/vial)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterility:\u003c\/strong\u003e Sterile, non-pyrogenic\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Intradermal injection (usually forearm site)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e TB screening, latent tuberculosis infection (LTBI) detection, annual health and occupational screenings\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Refrigerated (2-8°C)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eBest Uses \u0026amp; Clinical Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePublic Health \u0026amp; School TB Screening:\u003c\/strong\u003e Rapid, accurate TB detection for students, teachers, and staff members.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOccupational Health \u0026amp; Hospital Employee Testing:\u003c\/strong\u003e Ensure compliance and protect staff with CDC-recommended annual screening.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommunity Clinics \u0026amp; Prisons:\u003c\/strong\u003e Screen high-risk populations for latent and active tuberculosis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmigration \u0026amp; Visa Health Examinations:\u003c\/strong\u003e Essential for regulatory compliance in immigration processes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClose Contact Risk Assessment:\u003c\/strong\u003e Quickly assess TB exposure and infection among known contacts of TB-positive patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eKey Benefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eCDC-recommended concentration for maximum test sensitivity\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBulk 50-dose vial for efficient high-volume testing\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eReduces risk of false positives and patient reactions\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eEnsures safe, sterile intradermal administration\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSupports public health, compliance, and occupational safety standards\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eTop Medical \u0026amp; Health Search Terms\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eAplisol Tuberculin PPD\u003c\/li\u003e\n\u003cli\u003etuberculin skin test\u003c\/li\u003e\n\u003cli\u003ePPD skin test solution\u003c\/li\u003e\n\u003cli\u003eMantoux TB skin test\u003c\/li\u003e\n\u003cli\u003eTB screening test\u003c\/li\u003e\n\u003cli\u003epurified protein derivative test\u003c\/li\u003e\n\u003cli\u003e5 TU tuberculin test\u003c\/li\u003e\n\u003cli\u003eFDA approved TB skin test\u003c\/li\u003e\n\u003cli\u003elatent tuberculosis infection testing\u003c\/li\u003e\n\u003cli\u003eTB test for healthcare workers\u003c\/li\u003e\n\u003cli\u003eworkplace TB screening\u003c\/li\u003e\n\u003cli\u003eTB test for schools and public health\u003c\/li\u003e\n\u003cli\u003emulti-dose vial tuberculin\u003c\/li\u003e\n\u003cli\u003eintradermal TB test\u003c\/li\u003e\n\u003cli\u003etuberculosis PPD injection\u003c\/li\u003e\n\u003cli\u003eoccupational health TB testing\u003c\/li\u003e\n\u003cli\u003eannual TB skin test\u003c\/li\u003e\n\u003cli\u003ePPD 5 TU 0.1 mL\u003c\/li\u003e\n\u003cli\u003ePar Sterile Products Aplisol\u003c\/li\u003e\n\u003cli\u003eaccurate tuberculosis screening kit\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBrand: Par Sterile Products LLC\u003cbr\u003eNDC: 42023-0104-05\u003cbr\u003eUPC: 342023104052\u003cbr\u003eType: Multiple Dose Vial\u003c\/p\u003e\n\u003cp\u003eAplisol PPD (5 TU) is a tuberculosis skin test antigen given intradermally. A 0.1 mL injection yields 5 TU, the standard test dose. After injection, induration is measured at 48–72 hours. The size of induration (not redness) determines the likelihood of TB infection, with risk-based cutoffs (e.g. ≥5 mm in high-risk persons, ≥10 mm in moderate risk, ≥15 mm otherwise). Use caution in those with prior severe reactions (do not test again), and remember that BCG vaccination or non-tuberculous mycobacteria can affect results. Store Aplisol refrigerated (2–8 °C), discard vials after 30 days of use, and always have trained personnel administer and read the test.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eDisclaimer: This information is for educational purposes only. For personal medical advice (e.g. reading your own test, treatment of TB infection), consult a qualified healthcare provider.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eBuy Aplisol Tuberculin PPD Skin Test today for the #1 FDA-approved, physician-trusted TB screening solution and keep your facility compliant and protected!\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Par Sterile Products LLC","offers":[{"title":"Default Title","offer_id":12242823839816,"sku":"42023-0104-05","price":599.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tuberculin-Purified-Protein-Derivative-Diluted-Aplisol-by-Par-Sterile-NDC-42023-0104-05.jpg?v=1721933964"},{"product_id":"hepatitis-b-vaccine-recombivax-hb-adult-dialysis-vaccine-40-mcg-1-ml-single-dose-vial-preservative-free","title":"Hepatitis B Vaccine Recombivax HB Dialysis Formulation 40 mcg\/1 mL Single-dose Vial **Refrigerated Item","description":"\u003ch2\u003eUltimate Protection Against Hepatitis B | For Adults with Renal Failure, ESRD, Dialysis\u003c\/h2\u003e\n\u003cp\u003eProtect your health with \u003cstrong\u003eRecombivax HB Adult Dialysis Hepatitis B Vaccine (Recombinant) 40 mcg\/1 mL Single-dose Vial by Merck\u003c\/strong\u003e—the leading FDA-approved, CDC-recommended hepatitis B vaccine designed specifically for adults undergoing hemodialysis and living with chronic kidney disease (CKD) or end-stage renal disease (ESRD).\u003c\/p\u003e\n\u003cp\u003eThis high-potency hepatitis B vaccine delivers strong immunity for high-risk populations, helping prevent hepatitis B virus (HBV) infection, liver disease, cirrhosis, and hepatocellular carcinoma. Recombivax HB is the top choice for vaccination in the dialysis center and hospital settings, trusted by healthcare professionals and pharmacists nationwide.\u003c\/p\u003e\n\u003ch2\u003eKey Features:\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Dose Formula\u003c\/strong\u003e: 40 mcg\/1 mL single-dose vial—optimized for adult dialysis patients and immunocompromised individuals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecombinant DNA Technology\u003c\/strong\u003e: Provides safe, highly effective HBV surface antigen for strong, lasting immunity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-Dose Convenience\u003c\/strong\u003e: Easy, accurate dosing; reduces waste and cross-contamination risk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCDC \u0026amp; ACIP Recommended\u003c\/strong\u003e: Meets the latest guidelines for adult hepatitis B immunization, ESRD treatment, and infection control.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLeading Manufacturer\u003c\/strong\u003e: Produced by Merck—global leader in vaccine technology, quality, and safety.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eTop Health Benefits:\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevents Hepatitis B Infection\u003c\/strong\u003e: Protects against chronic and acute HBV, a major cause of liver failure, liver cancer, and death.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEssential for Dialysis Patients\u003c\/strong\u003e: Kidney failure and dialysis increase HBV risk—get protected now!\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBoosts Immune Response\u003c\/strong\u003e: Especially formulated for patients with weaker immune systems.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Transmission Risk\u003c\/strong\u003e: Reduces spread of hepatitis B in healthcare, dialysis clinics, and community settings.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWho Should Get the Recombivax HB Dialysis Vaccine?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eAdults (18+) starting or currently on hemodialysis or peritoneal dialysis\u003c\/li\u003e\n\u003cli\u003eIndividuals with chronic kidney disease (CKD stages 4-5)\u003c\/li\u003e\n\u003cli\u003ePatients awaiting kidney transplant\u003c\/li\u003e\n\u003cli\u003eHealthcare workers, nursing home staff, and other at-risk adults\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHow to Use:\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage \u0026amp; Administration\u003c\/strong\u003e: Inject intramuscularly (IM) as recommended (typically 3-dose series at 0, 1, and 6 months or as directed)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProfessional Use Only\u003c\/strong\u003e: For use by physicians, nurses, and healthcare professionals\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eIngredients \u0026amp; Safety:\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eContains recombinant hepatitis B surface antigen (HBsAg)\u003c\/li\u003e\n\u003cli\u003ePreservative-free formula\u003c\/li\u003e\n\u003cli\u003eNo human blood products or live virus\u003c\/li\u003e\n\u003cli\u003eMinimal side effects—commonly mild soreness at injection site\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContraindications\u003c\/strong\u003e: Allergic reaction to yeast or prior dose\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWhy Choose Recombivax HB by Merck?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e#1 prescribed hepatitis B vaccine in the USA for adults on dialysis\u003c\/li\u003e\n\u003cli\u003eBacked by decades of clinical research and global health experience\u003c\/li\u003e\n\u003cli\u003eMeets all US regulatory and quality standards for vaccine safety\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eOrder Now for Fast Shipping, Fresh Stock, and Unbeatable Pricing!\u003c\/h2\u003e","brand":"Merck","offers":[{"title":"Default Title","offer_id":39690167091272,"sku":"00006-4992-00","price":295.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Hepatitis-B-Vaccine-Recombivax-HB-Dialysis-Formulation-40-mcg.jpg?v=1758632891"},{"product_id":"hepatitis-a-vaccine-prefilled-syringes-single-dose-tip-lok-syringes-720el-u-0-5-ml-x-10-count-refrigerated-item","title":"Hepatitis A Vaccine Prefilled Syringes Single-Dose TIP-LOK Syringes 720EL. U. \/0.5 mL x 10 Count **Refrigerated Item**","description":"\u003cp\u003eHepatitis A Vaccine Prefilled Syringes Single-Dose TIP-LOK Syringes 720EL. U. \/0.5 mL x 10 Count. HAVRIX is indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan style=\"color: #ff2a00;\"\u003eNote: Non-Returnable Item\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: #ff2a00;\"\u003e\u003cstrong\u003eNon-Stock Item Ships in 2 to 3 days\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePreparation for Administration\u003c\/strong\u003e\u003cbr data-mce-fragment=\"1\"\u003eShake well before use. With thorough agitation, HAVRIX is a homogeneous, turbid, white suspension. Do not administer if it appears otherwise. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered. Attach a sterile needle to the prefilled syringe and administer intramuscularly.\u003c\/p\u003e\n\u003cp\u003eNDC: 58160-0825-52\u003c\/p\u003e\n\u003cp\u003eBrand: GSK Vaccines\u003c\/p\u003e\n\u003cp\u003eHavrix Vaccine Hepatitis A Vaccine Prefilled Syringes Single-Dose TIP-LOK Syringes \u003cbr\u003e\u003c\/p\u003e","brand":"GSK Vaccines","offers":[{"title":"Default Title","offer_id":39693410762824,"sku":"58160-0825-52","price":585.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/products\/Hepatitis-A-Vaccine-Prefilled-Syringes-Single-Dose-TIP-LOK-Syringes-720EL-U-0.5-mL-x-10-Count.jpg?v=1669124509"},{"product_id":"hyperrho-s-d-immune-globulin-whs-250u-250-mcg-prefilled-syringes-10-box","title":"Rho (D) Immune Globulin (Human) HyperRHO S\/D Mini-Dose 250 IU (50 MCG) Prefilled Syringes 10\/Box (Rx)","description":"HyperRHO® S\/D Mini-Dose (RhO[D] immune globulin [human]) is recommended to prevent the isoimmunization of RhO(D)-negative women at the time of spontaneous or induced abortion of up to 12 weeks' gestation provided the following criteria are met: The mother must be RhO(D) negative and must not already be sensitized to the RhO(D) antigen. The father is not known to be RhO(D) negative. Gestation is not more than 12 weeks at termination.\n\u003cp\u003eHyperRHO S\/D is an immune globulin with a high level of preformed antibodies against rhesus (Rh)-positive blood cells.\u003cbr\u003eThe injection of an RHO(D) immune globulin provides a passive immunity for rapid immune protection and an acute response in high-risk situations.\u003cbr\u003eHyperRHO S\/D destroys any Rh-positive blood cells that may have entered the mother's bloodstream and prevents the mother's immune system from producing Rh-positive antibodies, thus protecting the baby from developing hemolytic disease.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eEach single-dose syringe of HyperRHO S\/D contains sufficient anti-RhO(D) to effectively suppress the immunizing potential of 15 mL of Rh-positive red blood cells.\u003cbr\u003e\u003cbr\u003eAntepartum and postpartum administration of a single dose of HyperRHO S\/D to susceptible Rh-negative women reduces the incidence of Rh isoimmunization to less than 0.1%.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEffective Protection\u003c\/strong\u003e\u003cbr\u003eHyperRHO S\/D destroys Rh-positive cells in the mother's body, prevents the mother's immune system from producing Rh-positive antibodies, and protects the baby from contracting HDN.\u003cbr\u003e\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"Default Title","offer_id":39924081033288,"sku":"13533-0661-06","price":449.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Rho-_D_-Immune-Globulin-_Human_-HyperRHO-by-Grifols-Therapeutics.jpg?v=1725625340"},{"product_id":"hyperrho-s-d-whs-immune-globulin-full-dose-300u-300-mcg-prefilled-syringes-1-box","title":"HyperRHO S\/D WHS, Immune Globulin Full-Dose  300U (300 MCG) Prefilled Syringe 1\/Box (Rx) *Refrigerated*","description":"\u003cp\u003eHyperRHO® S\/D Full Dose (RhO[D] immune globulin [human]) is indicated for the prevention of Rh HDN and the prevention of isoimmunization in RhO(D)-negative individuals who have been transfused with RhO(D)-positive red blood cells.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e* Refrigerated Item, Ships Next Day Air, SIGNATURE REQUIRED *\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eHyperRHO S\/D is an immune globulin with a high level of preformed antibodies against rhesus (Rh)-positive blood cells.\u003cbr\u003eThe injection of an RHO(D) immune globulin provides a passive immunity for rapid immune protection and an acute response in high-risk situations.\u003cbr\u003eHyperRHO S\/D destroys any Rh-positive blood cells that may have entered the mother's bloodstream and prevents the mother's immune system from producing Rh-positive antibodies, thus protecting the baby from developing hemolytic disease.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eEach single-dose syringe of HyperRHO S\/D contains sufficient anti-RhO(D) to effectively suppress the immunizing potential of 15 mL of Rh-positive red blood cells.\u003cbr\u003e\u003cbr\u003eAntepartum and postpartum administration of a single dose of HyperRHO S\/D to susceptible Rh-negative women reduces the incidence of Rh isoimmunization to less than 0.1%.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEffective Protection\u003c\/strong\u003e\u003cbr\u003eHyperRHO S\/D destroys Rh-positive cells in the mother's body, prevents the mother's immune system from producing Rh-positive antibodies, and protects the baby from contracting HDN.\u003cbr\u003e\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"Default Title","offer_id":39924081590344,"sku":"13533-0631-02","price":189.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/RHO-Immune-Globulin-_Human_-300-mcg-by-Grifols-13533-0631-02.jpg?v=1724353748"},{"product_id":"typhoid-vaccine-vi-capsular-polysaccharide-vaccine-single-dose-prefilled-syringe-25mcg-0-5ml","title":"Typhoid Vaccine (Vi Capsular Polysaccharide Vaccine) Single-Dose Prefilled Syringe 25mcg\/0.5mL  **Refrigerated Item","description":"\u003cp\u003eTyphoid Vaccine (Vi Capsular Polysaccharide Vaccine) for the best prices at Mountainside Medical Equipment.\u003cbr\u003e\u003c\/p\u003e\nTyphoid fever is a serious bacterial infection caused by Salmonella typhi. It can be fatal, especially in young children. The typhoid vaccine is a preventive measure against typhoid fever. It is a single-dose, injectable vaccine that contains the Vi capsular polysaccharide of Salmonella typhi. The vaccine is highly effective in preventing typhoid fever. It is approved for use in individuals aged two years and older. The vaccine is given as a single dose by injection. It is generally well tolerated. Minor adverse effects may include fever, headache, and muscle aches. The typhoid vaccine is safe and effective and should be considered by travellers to areas where typhoid fever is common.\n\u003cp\u003e\u003cstrong\u003eWhat is Typhoid Vaccine?\u003c\/strong\u003e\u003cbr\u003eTyphoid vaccine is a vaccine that protects against typhoid fever. It works by exposing you to a weak form of the typhoid bacteria or by giving you a vaccine composed of dead bacteria.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eHow does Typhoid Vaccine work?\u003c\/strong\u003e\u003cbr\u003eThe vaccine helps prepare your body in advance by stimulating the production of antibodies to the capsular polysaccharide of Salmonella typhi, the organism that causes typhoid fever. If you are exposed to typhoid fever, these antibodies will help protect you from becoming sick.\u003c\/p\u003e\n\u003cp\u003eSalmonella typhi is a bacterium that causes typhoid fever. It is a Gram-negative, rod-shaped bacterium that is a facultative anaerobe. It is a member of the family Enterobacteriaceae. typhoid fever is a serious disease caused by the bacterium Salmonella typhi. It is a type of food poisoning that can be fatal. The disease is spread by eating food or drinking water that is contaminated with the bacterium. typhoid fever typically causes fever, diarrhea, and vomiting. It can also cause rash, chest pain, and headache. The course of the disease can vary from mild to severe. In severe cases, the person may develop a life-threatening condition called typhoid shock. typhoid fever is a serious disease and can be fatal. It is important to see a doctor if you develop symptoms of the disease.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eWho should get Typhoid Vaccine?\u003c\/strong\u003e\u003cbr\u003eThe vaccine is recommended for people who are planning to travel to areas where typhoid fever is common, such as Asia, Africa, and South America. It is also recommended for people who work in or visit close-contact settings such as hospitals, child care centers, and laboratories where typhoid fever is a possibility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\nTyphoid fever is a potentially life-threatening infection caused by the bacteria Salmonella Typhi. It is estimated that there are over 20 million cases of typhoid fever worldwide each year, with more then 200,000 deaths. Typhoid fever is most common in developing countries, but can also occur in industrialized nations. The disease can be spread through food or water that is contaminated with the bacteria, or from contact with an infected person. Symptoms of typhoid fever can include fever, diarrhea, abdominal pain, and vomiting.There is no specific cure for typhoid fever, but it can be treated with antibiotics. Prevention of the disease is through vaccination and good hygiene practices. The typhoid fever vaccine is a live, attenuated vaccine that is given as a single dose by injection. The vaccine is approximately 80-85% effective in preventing typhoid fever. There are several different strains of the typhoid fever vaccine, so be sure to check with your health care provider to see if you are eligible for the typhoid fever vaccine.","brand":"Sanofi Pasteur","offers":[{"title":"Default Title","offer_id":39956532396104,"sku":"49281-0790-51","price":245.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Typhoid-Vaccine-_Vi-Capsular-Polysaccharide-Vaccine_-Single-Dose-Prefilled-Syringe-25mcg-0.5mL.jpg?v=1685975378"},{"product_id":"vivotif-typhoid-vaccine-liver-oral-ty21a-capsules-4-box-refrigerated-item","title":"Vivotif (Typhoid Vaccine Live Oral Ty21a) Capsules, 4\/Box  **Refrigerated Item","description":"\u003cp\u003eVivotif (Typhoid Vaccine Live Oral Ty21a) is an oral vaccine used to prevent typhoid fever, a serious illness caused by the bacterium Salmonella Typhi. It is commonly recommended for travelers visiting regions where typhoid fever is prevalent. By stimulating the immune system to recognize and fight the bacteria, Vivotif provides effective protection against the disease. Administered in capsule form, it requires completion of the full dosage schedule for maximum efficacy. Always follow healthcare advice regarding travel vaccinations for optimal safety.\u003c\/p\u003e\n\u003cp\u003eEmbark on your global adventures confidently with Vivotif, the premier oral typhoid vaccine by Emergent Travel Health. Specially designed for travelers heading to regions where typhoid fever is common, Vivotif provides an effective and convenient way to protect against this potentially severe disease. Each box contains 4 easy-to-take capsules, offering a hassle-free vaccination experience tailored for those on the move. Trust in the science of immunization with Vivotif, and prioritize your health on every journey.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Live attenuated Ty21a strain delivers strong immunity against Salmonella Typhi.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Pack: \u003c\/strong\u003eContains 4 individually sealed capsules, sufficient for a complete vaccination course.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Oral Administration:\u003c\/strong\u003e Bypasses the need for injections, making it suitable for those who prefer an alternative route.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEffective Duration: \u003c\/strong\u003eProvides up to 5 years of protection against typhoid fever following the full dosing schedule.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVivotif utilizes a live attenuated strain of the Ty21a Salmonella Typhi bacterium. Upon oral administration, the attenuated bacteria stimulate the immune system to recognize and mount a defense against Salmonella Typhi without causing illness. This immunological response builds protective memory, equipping the body to respond swiftly and effectively upon future exposure to the pathogen.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Dosage Schedule: \u003c\/strong\u003eTake one capsule every other day. Complete the series of 4 capsules over the course of one week.\u003cbr\u003e\u003cstrong\u003e2. Administration:\u003c\/strong\u003e Swallow each capsule whole with cold or lukewarm water one hour before a meal. Do not chew or break the capsules.\u003cbr\u003e\u003cstrong\u003e3. Timing:\u003c\/strong\u003e Complete the full vaccination course at least one week prior to potential exposure to Salmonella Typhi.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmunocompromised Individuals:\u003c\/strong\u003e Not recommended for individuals with weakened immune systems, as the vaccine contains a live attenuated bacterium.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAcute Illness:\u003c\/strong\u003e Avoid during acute febrile illnesses. Wait until recovery before starting the vaccine.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntibiotic Interaction:\u003c\/strong\u003e Ensure no antibiotic intake during and for 3 days before and after taking the course to maintain its efficacy.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImportant Precautions:\u003c\/strong\u003e Avoid simultaneous administration with malaria prophylaxis; consult healthcare providers for more information.\u003cbr\u003e  \u003cbr\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eCommon side effects may include:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAbdominal discomfort\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eNausea\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eDiarrhea\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eMild rash\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eMost side effects are mild and resolve on their own. If severe reactions or symptoms such as breathing difficulties, high fever, or prolonged gastrointestinal issues occur, seek medical attention immediately. Always consult with your healthcare provider prior to starting Vivotif to address any questions, health concerns, or to discuss its compatibility with your travel plans and health status. \u003c\/p\u003e\n\u003cp\u003eChoosing Vivotif ensures you're taking responsible steps to protect your health, allowing you to focus on experiencing the world with peace of mind.\u003c\/p\u003e","brand":"Emergent Travel Health Inc","offers":[{"title":"Default Title","offer_id":39956533149768,"sku":"69401-0000-02","price":199.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Typhoid-Vaccine-Live-Oral-Ty21a.jpg?v=1731690799"},{"product_id":"cholera-vaccine-vaxchora-recombinant-live-oral-single-dose-100ml-refrigerated-item","title":"Cholera Vaccine Vaxchora Recombinant Live Oral Vaccine For Cholera Infection Prevention When Traving 100 mL **Refrigerated","description":"\u003ch3\u003e\u003cstrong\u003eUltimate Protection for International Travelers Against Cholera\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eTraveling to regions with a high risk of cholera? Safeguard yourself with the Cholera Vaccine Vaxchora (Recombinant Live Oral) 100 mL single-dose by Bavarian Nordic Inc.—the only FDA-approved, orally administered, single-dose cholera vaccine for adults and children ages 2–64. Ensure your travel health and peace of mind with rapid and effective defense against Vibrio cholerae.\u003c\/p\u003e\n\u003ch3\u003eWhat is Vaxchora Cholera Vaccine?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eVaxchora\u003c\/strong\u003e is a groundbreaking \u003cstrong\u003erecombinant live oral cholera vaccine\u003c\/strong\u003e designed to protect against cholera infection caused by \u003cstrong\u003eVibrio cholerae serogroup O1\u003c\/strong\u003e. This innovative vaccine is scientifically proven to help prevent \u003cstrong\u003esevere diarrhea\u003c\/strong\u003e and \u003cstrong\u003edehydration\u003c\/strong\u003e associated with cholera—an essential for travelers heading to endemic areas, including Asia, Africa, Latin America, and the Caribbean.\u003c\/p\u003e\n\u003ch3\u003eKey Features \u0026amp; Top Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOne Dose Protection:\u003c\/strong\u003e Single-dose 100 mL regimen for fast, long-lasting cholera immunity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA-Approved \u0026amp; Recommended:\u003c\/strong\u003e Trusted by the CDC and WHO for safe and effective cholera prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIdeal for International Travelers \u0026amp; Humanitarian Workers:\u003c\/strong\u003e Protects adults and children (ages 2–64) visiting cholera-prone destinations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Oral Administration:\u003c\/strong\u003e No injections needed; easy-to-administer oral solution.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad Global Protection:\u003c\/strong\u003e Effective within just 10 days, with protection lasting up to 3 months.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Travelers Need Cholera Vaccine:\u003c\/h3\u003e\n\u003cp\u003eThe \u003cstrong\u003eCDC\u003c\/strong\u003e and \u003cstrong\u003eWorld Health Organization\u003c\/strong\u003e recommend vaccination for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdventurers, backpackers, and business travelers\u003c\/li\u003e\n\u003cli\u003eMissionaries and health professionals in outbreak regions\u003c\/li\u003e\n\u003cli\u003eEmergency responders and disaster relief workers\u003c\/li\u003e\n\u003cli\u003eIndividuals visiting friends and family in endemic countries\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eTravel tip: Cholera outbreaks can happen suddenly. Be prepared with Vaxchora before your trip!\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eDosage \u0026amp; Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e Single 100 mL dose (one-time administration)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e Take at least 10 days prior to potential cholera exposure or before departure to high-risk countries.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHow to Take:\u003c\/strong\u003e Vaxchora is supplied as a powder for oral suspension—mix with purified water to create a 100 mL solution. Drink the entire contents in one sitting. \u003cstrong\u003eDo not eat or drink for 60 minutes before and after dosing.\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAge Range:\u003c\/strong\u003e Approved for travelers aged 2 to 64 years.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eConsult your healthcare provider for travel health planning and vaccine timing.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003ePossible Side Effects\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTiredness\/Fatigue\u003c\/li\u003e\n\u003cli\u003eHeadache\u003c\/li\u003e\n\u003cli\u003eAbdominal pain\/cramps\u003c\/li\u003e\n\u003cli\u003eNausea or vomiting\u003c\/li\u003e\n\u003cli\u003eFever\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRare Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDiarrhea\u003c\/li\u003e\n\u003cli\u003eAllergic reactions (swelling, itching, difficulty breathing)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious reactions are extremely rare.\u003c\/strong\u003e Consult your doctor if you experience persistent symptoms or allergic reactions.\u003c\/p\u003e\n\u003ch3\u003eFrequently Asked Questions\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Do I need the cholera vaccine for travel?\u003c\/strong\u003e A: If you’re traveling to a country with active cholera transmission, the CDC and WHO recommend vaccination to prevent serious illness.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How long before I travel should I take Vaxchora?\u003c\/strong\u003e A: Take at least 10 days before possible exposure for maximum protection.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Can children take Vaxchora?\u003c\/strong\u003e A: Yes, for ages 2–64 with healthcare provider recommendation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTags:\u003c\/strong\u003e \u003cspan class=\"VODHU pdMy8\"\u003echolera vaccine, Vaxchora, oral cholera vaccine, cholera prevention, Vibrio cholerae protection, travel vaccines, travel health, travel immunizations, international vaccine requirements, what is the cholera vaccine, cholera vaccine dosage, cholera vaccine side effects, cholera vaccine for travelers, Bavarian Nordic vaccine, CDC recommended vaccines, travel immunization clinic, FDA approved oral vaccine, best vaccine for cholera, single-dose vaccine, cholera protection for travel.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eOrder Cholera Vaccine Vaxchora Single-dose 100 mL by Bavarian Nordic Inc. Today!\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e#1 FDA-approved cholera vaccine trusted by international travelers\u003c\/li\u003e\n\u003cli\u003eFast, safe, and effective—take once for trip-long peace of mind\u003c\/li\u003e\n\u003cli\u003eIdeal for adults \u0026amp; children traveling to Africa, Asia, Caribbean, Latin America, and disaster regions\u003c\/li\u003e\n\u003cli\u003eDirect shipping to travel clinics, pharmacies, and individuals\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePrepare for a healthy journey—get protected with Vaxchora, the leading oral cholera vaccine!\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan class=\"VODHU pdMy8\"\u003eDon’t risk your travel health—choose Vaxchora for powerful cholera defense wherever your journey takes you! Order now or visit your travel health clinic today.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"Bavarin Nordic inc","offers":[{"title":"Default Title","offer_id":39956546584648,"sku":"50632-0015-02","price":495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Cholera-Vaccine-Vaxchora-_Recombinant-Live-Oral_-Single-dose-100mL.jpg?v=1685979333"},{"product_id":"pneumovax-23-pneumococcal-vaccine-polyvalent-vaccine-0-5-ml-syringes-10-box-requires-refrigeration","title":"Pneumovax 23 (Pneumococcal Vaccine Polyvalent) Vaccine 0.5 mL Syringes 10\/Box  *Requires Refrigeration","description":"\u003cp\u003ePneumovax 23 (Pneumococcal Vaccine Polyvalent) Vaccine 0.5 mL is a vaccine that helps protect adults against diseases caused by pneumococcal bacteria, including pneumonia, meningitis, and blood infections. Pneumococcal bacteria can also cause ear and sinus infections. Pneumococcal bacteria are common and can cause serious illness in adults of all ages.\u003c\/p\u003e\n\u003cp\u003ePneumococcal Vaccine Polyvalent (Pneumovax 23) is a vaccine used to prevent infection by the pneumococcus bacteria. It can be given in 3 ways; 1) by injection into a muscle, 2) more rarely, by directly into a blood vessel (intravenous), or 3) using a special inhaled device. Treatment given most often is a shot pushed under the skin (subcutaneous) in the upper arm or thigh muscle. It can also be given as an injection into spinal fluid through a process called intrathecal administration,administrated through a device called Spherovax II 26 Gauge needles for intradermal, muscular and subcutaneous subcutaneous administration.\u003c\/p\u003e","brand":"Merck","offers":[{"title":"Default Title","offer_id":39958220767304,"sku":"00006-4837-03","price":1650.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Pneumovax-23-_Pneumococcal-Vaccine-Polyvalent_-Vaccine-0.5-mL-Syringes.jpg?v=1686240413"},{"product_id":"vaxneuvance-vaccine-pneumococcal-15-valent-conjugate-vaccine-0-5ml-x-10-box-requires-refrigeration","title":"Vaxneuvance Vaccine (Pneumococcal 15-valent Conjugate Vaccine) 0.5mL Syringes x 10\/Box *Requires Refrigeration","description":"\u003cp\u003e\u003cstrong\u003eNext Generation Pneumococcal Disease Protection\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVaxneuvance (Pneumococcal 15-valent Conjugate Vaccine, PCV15, NDC: 00006-4329-03 is the advanced, FDA-approved solution for the prevention of invasive disease caused by Streptococcus pneumoniae in both adults and children. Each prefilled 0.5mL syringe delivers powerful, broad-spectrum protection against 15 key pneumococcal serotypes, offering a longer and stronger immune response compared to earlier-generation vaccines. Supplied in convenient 10-count boxes, Vaxneuvance is the preferred choice for clinics, health systems, pharmacies, and pediatric offices committed to top-tier patient immunization and public health.\u003c\/p\u003e\n\u003ch2\u003eFeatures \u0026amp; Benefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnhanced 15-Valent Pneumococcal Coverage:\u003c\/strong\u003e Immunizes against 15 clinically relevant \u003cem\u003eStreptococcus pneumoniae\u003c\/em\u003e serotypes, expanding on traditional Prevnar and Pneumovax coverage for broader defense.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePre-filled 0.5mL Syringes:\u003c\/strong\u003e Ready to administer, ensuring dosing accuracy, convenience, and safety for healthcare professionals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA Approved for Adults and Children:\u003c\/strong\u003e Indicated for immunization of infants, children, adolescents, and adults for comprehensive age group protection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHelps Prevent Serious Pneumococcal Diseases:\u003c\/strong\u003e Significantly reduces risk of invasive pneumococcal diseases (IPD) including pneumonia, bacteremia, meningitis, and septicemia.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports CDC and ACIP Immunization Schedules:\u003c\/strong\u003e Fully meets CDC and ACIP recommendations for routine and high-risk populations, including seniors and immunocompromised.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSafe \u0026amp; Well-Tolerated:\u003c\/strong\u003e Proven high safety profile with minimal adverse events in clinical studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e10 per Box – Ideal for Clinics \u0026amp; Pharmacies:\u003c\/strong\u003e Optimized for high-throughput settings with easy inventory management.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRefrigerator Stable:\u003c\/strong\u003e Convenient cold storage for effortless integration into existing vaccine supplies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eIndications \u0026amp; Patient Benefits\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eVaxneuvance (Pneumococcal 15-valent Conjugate Vaccine)\u003c\/strong\u003e is indicated for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eChildren as young as 6 weeks through adulthood\u003c\/li\u003e\n\u003cli\u003eAdults aged 18 years and older, especially those 65+ or with chronic health conditions (e.g., diabetes, heart disease, COPD, asthma)\u003c\/li\u003e\n\u003cli\u003eIndividuals with immunocompromising conditions or functional\/anatomic asplenia\u003c\/li\u003e\n\u003cli\u003eAnyone at increased risk for pneumococcal pneumonia, bacteremia, meningitis, and severe pneumococcal complications\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eKey advantages for patients:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eReduces risk of life-threatening pneumococcal infections\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevents antibiotic-resistant strains of pneumonia\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eLinks to improved long-term respiratory and overall health\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eReduces hospitalizations, healthcare costs, and caregiver burden\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWhy Choose Vaxneuvance (PCV15) for Your Clinic?\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eVaxneuvance PCV15\u003c\/strong\u003e delivers advanced, next-generation protection against pneumococcal disease—with robust immune response, broad serotype coverage, exceptional safety, and ease of use in all healthcare settings. Trusted by pediatricians, internists, geriatricians, and immunizers nationwide, Vaxneuvance helps meet and exceed public health goals for pneumococcal disease prevention.\u003c\/p\u003e\n\u003ch2\u003eProduct Specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eName:\u003c\/strong\u003e Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e 0.5mL pre-filled syringe\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuantity:\u003c\/strong\u003e 10 syringes per box\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAge Indication:\u003c\/strong\u003e 6 weeks and above (children, adults, seniors)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Intramuscular injection (IM)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Refrigerate (2°C to 8°C\/36°F to 46°F)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e [Insert Manufacturer, e.g., Merck \u0026amp; Co.]\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNDC: \u003c\/strong\u003e00006-4329-03\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eStock your facility with the most up-to-date, CDC-recommended, FDA-approved protection—Vaxneuvance Vaccine (Pneumococcal 15-valent Conjugate Vaccine) 0.5mL Syringes x 10\/Box. Safeguard your community, improve outcomes, and prevent the spread of serious pneumococcal infections.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eAvailable for immediate order. Wholesale pricing for clinics, health systems, and pharmacies. Contact us for more information or bulk purchases!\u003c\/em\u003e\u003c\/p\u003e","brand":"Merck","offers":[{"title":"Default Title","offer_id":39958698000456,"sku":"00006-4329-03","price":3200.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Vaxneuvance-Vaccine-Pneumococcal-15-valent-Conjugate-Vaccine-0.5mL-Syringes.jpg?v=1686244856"},{"product_id":"rsv-vaccine-rsvpref3-antigen-as01e-pf-respiratory-synctial-virus-vaccine-10-doses-60-year-refrigerated-item","title":"Arexvy RSV Vaccine RSVPreF3 Antigen-AS01E (PF) Respiratory Syncytial Virus Vaccine 10 Doses ** Refrigerated Item","description":"\u003cp\u003eThe RSV Vaccine RSVPreF3 Antigen-AS01E (PF) Respiratory Synctial Virus Vaccine is used to prevent or reduce the severity of respiratory syncytial virus (RSV) infection in individuals who are 60 years of age or older. It works by triggering the body to produce protective antibodies in order to fight the RSV virus. The shots contain a single dose of ovalbumin-based recombinant RSV fusion protein-containing alum-adjuvanted immunogen, a substance that causes the person to create antibodies. Typically, those who are given the vaccine will require two doses of the vaccine each month apart in order to build up immunity and are advised to start the vaccination series six months before RSV season.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits of Arexvy RSV Vaccine\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDevelops immunity against the disease-causing Respiratory Syncytial Virus (RSV)\u003c\/li\u003e\n\u003cli\u003eProvides up to 90% reduction of severe disease, including hospitalizations and deaths, caused by RSV, in children\u003c\/li\u003e\n\u003cli\u003eReduces RSV-associated lower respiratory tract disease and bronchiolitis episodes in infants and 1-11 month old infants\u003c\/li\u003e\n\u003cli\u003eHas been proven safe for multiple-dose administration\u003c\/li\u003e\n\u003cli\u003eMay help protect against RSV-associated ear and\/or nose and throat infections\u003c\/li\u003e\n\u003cli\u003eHas been administered to more than 1.2 million infants and children without serious safety concerns\u003c\/li\u003e\n\u003cli\u003eEffective in protecting premature infants from severe RSV disease, while being safe and well tolerated when given to young infants\u003c\/li\u003e\n\u003cli\u003eIs given as a two-stage injection series during RSV season, to babies aged 6 to 24 months in Europe and Asia and older children 9 to 24 months in Latin America\u003c\/li\u003e\n\u003cli\u003eRSV Pre F3 Antigen AS01E (PF) is a subunit recombinant vaccine composed of F and G components, proteins that are intrinsic to the RSV virus strain responsible for causing disease worldwide\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe RSV Vaccine RSVPreF3 Antigen-AS01E (PF) Respiratory Syncytial Virus Vaccine provides immunization and protection against the virus. It's especially important for children six months of age and younger as they are at increased risk for potential respiratory infections from the virus. The RSV Vaccine is created from a single dose of a molecularly-attenuated and purified RSV strain, providing a strong immune response against the virus. After a single dose of the RSV Vaccine, a person should be immunized for approximately one year. The RSV Vaccine 10 dose package provides individuals with full immunization for at least ten years of reliable protection against the virus. Consequently, the RSV Vaccine is a powerful tool in preventing respiratory infections caused by RSV.\u003c\/p\u003e","brand":"GSK Vaccines","offers":[{"title":"Default Title","offer_id":39980199739464,"sku":"58160-0848-11","price":3950.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/RSV-Vaccine-RSVPreF3-Antigen-AS01E-_PF_-Respiratory-Syncytial-Virus-Vaccine-10-Doses.jpg?v=1743429642"},{"product_id":"abrysvo-rsv-vaccine-respiratory-syncytial-virus-vaccine-pfizer-uspg","title":"Abrysvo RSV Vaccine 0.5 mL Kit for RSV by Pfizer USPG 5\/Box (Rx) **Refrigerated","description":"\u003cp\u003eProtect your patients from severe respiratory infections with Abrysvo RSV Vaccine—the advanced, FDA-approved solution for the prevention of Respiratory Syncytial Virus (RSV) in high-risk groups. Trusted worldwide and developed by Pfizer, Abrysvo is your top choice for comprehensive RSV immunization for older adults and pregnant women to safeguard newborns.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cem\u003e\u003cstrong\u003eNote: This product ships signature required. Non-returnable\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cem\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eProduct Highlights \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroad-Spectrum RSV Protection:\u003c\/strong\u003e Prevents severe RSV infection, lower respiratory tract disease, and complications such as pneumonia and bronchiolitis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Created by Pfizer USPG, a global leader in vaccine innovation and respiratory disease prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA-Approved \u0026amp; CDC Recommended:\u003c\/strong\u003e Meets the highest safety and efficacy standards for RSV vaccination.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Coverage:\u003c\/strong\u003e Indicated for older adults (60+), pregnant women for maternal immunization, and protection for infants during RSV season, following CDC guidelines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Packaging:\u003c\/strong\u003e 5 premeasured 0.5 mL kits per box for easy administration in clinics and hospitals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEasy Administration:\u003c\/strong\u003e Intramuscular injection designed for efficient workflow in healthcare settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Hospitalizations:\u003c\/strong\u003e Significantly lowers the risk of RSV-related respiratory complications and hospital admissions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Health Terms for this product.\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAbrysvo vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRespiratory syncytial virus vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine for adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFDA approved RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePfizer RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for older adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMaternal RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eProtect infants from RSV\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevention of RSV in babies\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSenior vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePregnancy vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC recommended vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRespiratory infection prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eLower respiratory tract infection vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent RSV pneumonia\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunization for pregnant women\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for newborn protection\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine side effects\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for high-risk patients\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent bronchiolitis\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBest respiratory vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Abrysvo RSV Vaccine by Pfizer?\u003c\/h3\u003e\n\u003cp\u003eRespiratory Syncytial Virus (RSV) is a major cause of serious respiratory illness in infants, older adults, and those with chronic medical conditions. \u003cem\u003eAbrysvo\u003c\/em\u003e is specially formulated to provide powerful immunity against RSV, reducing the risk of life-threatening complications such as pneumonia and bronchiolitis. \u003cstrong\u003eAbrysvo is especially important for:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOlder Adults (Aged 60+):\u003c\/strong\u003e Protect against severe lower respiratory tract disease and reduce RSVP hospital admissions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant Women:\u003c\/strong\u003e Transfer protective antibodies to unborn babies, reducing the risk of RSV infection and hospitalizations in newborns.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh-Risk Individuals:\u003c\/strong\u003e Boost immunity in people with chronic heart or lung disease or weakened immune systems.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWith the seasonality and unpredictability of RSV outbreaks, timely and effective vaccination with Pfizer’s Abrysvo is the gold standard for safeguarding public health.\u003c\/p\u003e\n\u003ch3\u003eUsage \u0026amp; Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e 0.5 mL per intramuscular injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e 5 kits per box, ideal for clinics and healthcare providers\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e Single-dose vaccine per CDC and FDA guidelines\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e Adults 60+, pregnant women (third trimester) to protect newborns, and those at increased risk for severe RSV disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety Information\u003c\/h3\u003e\n\u003cp\u003eAbrysvo has a strong safety profile with extensive clinical research. The most common side effects are mild and short-lived, such as injection site pain, redness, fatigue, headache, or muscle aches. Severe allergic reactions are extremely rare. Consult a healthcare professional regarding individual health conditions, medical history, and possible interactions.\u003c\/p\u003e\n\u003ch3\u003eOrder Abrysvo RSV Vaccine Today\u003c\/h3\u003e\n\u003cp\u003eStay prepared for RSV season with \u003cstrong\u003eAbrysvo RSV Vaccine 0.5 mL Kit x 5\/Box by Pfizer USPG\u003c\/strong\u003e—the best-in-class solution for comprehensive RSV protection. Stock your practice or healthcare facility to meet CDC and FDA recommendations and protect patients of all ages from serious respiratory complications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Abrysvo now for advanced protection against RSV in adults, pregnant women, and newborns—trusted worldwide for respiratory health and wellness.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":39980445270088,"sku":"00069-0344-05","price":2075.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Abrysvo-RSV-Vaccine-_Respiratory-Syncytial-Virus-Vaccine_-0.5-mL.jpg?v=1756387364"},{"product_id":"abrysvo-rsv-vaccine-respiratory-syncytial-virus-vaccine-0-5-ml-kit-1-kit-refrigerated-item","title":"Abrysvo RSV Vaccine (Respiratory Syncytial Virus Vaccine) 0.5 mL Kit (Rx) **Refrigerated Item","description":"\u003ch1\u003eAbrysvo (RSV Vaccine) 0.5 mL Injection\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eAbrysvo is a \u003cstrong\u003evaccine\u003c\/strong\u003e made by Pfizer that protects against \u003cstrong\u003erespiratory syncytial virus (RSV)\u003c\/strong\u003e, a common respiratory virus that can cause serious lung infections (lower respiratory tract disease, like bronchitis or pneumonia) in infants and older adults. Abrysvo is a \u003cstrong\u003ebivalent recombinant subunit vaccine\u003c\/strong\u003e – it contains laboratory-made versions of the RSV \u003cstrong\u003efusion (F) protein\u003c\/strong\u003e (from both RSV-A and RSV-B strains) in its “prefusion” stabilized form. When injected, these harmless viral proteins stimulate the immune system to produce antibodies, so the body can fight off RSV if exposed later. Abrysvo does not contain live virus, so it cannot cause RSV.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cspan class=\"VODHU pdMy8\"\u003eWho should get Abrysvo? \u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eAbrysvo has three main indications:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant individuals (32–36 weeks gestation):\u003c\/strong\u003e If given between about 32–36 weeks of pregnancy, Abrysvo protects the newborn against RSV from birth up to 6 months of age. The maternal antibodies cross the placenta to protect the baby after birth. (It is the first RSV vaccine approved for use during pregnancy in the US.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults 60 years and older:\u003c\/strong\u003e A single dose is approved to prevent serious RSV lung disease in seniors. Clinical trials showed Abrysvo reduced the risk of lower respiratory RSV infection in older adults by about 67%..\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults 18–59 at high risk:\u003c\/strong\u003e Adults in this age range who have certain medical conditions (e.g. chronic heart or lung disease, diabetes, immunosuppression, etc.) are also recommended to receive one dose to prevent RSV lung infection.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e(Official use may vary slightly by country’s guidelines. The FDA and EMA approvals match these groups.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage and Administration:\u003c\/strong\u003e Abrysvo is given \u003cstrong\u003eintramuscularly\u003c\/strong\u003e (IM) as a 0.5 mL injection (a single dose) in the upper arm (deltoid). Before injection, the vial is reconstituted (mixed) with a diluent to make the dose. No booster series is currently recommended – just \u003cstrong\u003eone dose per pregnancy\u003c\/strong\u003e (if pregnant) or per RSV season for adults. For pregnant patients, the dose should be administered \u003cstrong\u003ebetween 32 and 36 weeks of gestation\u003c\/strong\u003e (EMA says 24–36 weeks; FDA says 32–36). If an adult misses a season, the vaccine should still be given when possible; it is not given at the same time as yearly flu shots unless coadministration is studied.\u003c\/p\u003e\n\u003cp\u003eBecause Abrysvo is a protein vaccine, it must be handled like other injectables: use a new sterile syringe and needle, inject slowly into muscle, and observe standard vaccine precautions. After injection, monitor the patient for a short time for any immediate reactions.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEffectiveness:\u003c\/strong\u003e Studies have shown that Abrysvo provides strong protection: in seniors, it prevented about two-thirds of RSV lung disease cases; in pregnant women’s babies, it cut RSV illness by about half in the first 6 months of life. (Vaccine-induced antibodies to the RSV prefusion F protein are believed to neutralize the virus on contact.) Protection is expected to last throughout the RSV season (several months).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Most people tolerate Abrysvo well. The \u003cstrong\u003emost frequent side effects\u003c\/strong\u003e (seen in more than 10% of recipients) are mild and short-lived:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection site reactions:\u003c\/strong\u003e pain, redness or swelling where the shot was given.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGeneral symptoms:\u003c\/strong\u003e fatigue\/tiredness, headache, muscle aches (myalgia), sometimes fever or chills. These usually begin within 1–2 days of vaccination and resolve in a few days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIn pregnant recipients:\u003c\/strong\u003e similar side effects – injection site pain, headache, muscle aches are most common.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious Risks:\u003c\/strong\u003e As with any vaccine, serious problems are rare. Key warnings include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergy:\u003c\/strong\u003e Watch for any sign of a severe allergic reaction (hives, swelling of face\/throat, difficulty breathing, dizziness). If this happens (typically within minutes of the shot), emergency treatment is needed. Anaphylaxis has been reported with many vaccines (though it’s very uncommon).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGuillain-Barré Syndrome (GBS):\u003c\/strong\u003e FDA requires a warning that a very small increased risk of GBS (an immune-mediated nerve problem causing weakness) has been observed within about 6 weeks after Abrysvo. The estimated excess is on the order of \u003cstrong\u003e7–9 extra GBS cases per million doses\u003c\/strong\u003e in older adults. The overall evidence suggests a possible association, but it’s still very rare. Patients should be instructed to seek care if they experience unusual weakness or tingling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune-mediated conditions:\u003c\/strong\u003e There have been very few reports of immune reactions (like autoimmune neurologic events) in trials. Patients with a history of the same (e.g. history of GBS) should discuss with their doctor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther:\u003c\/strong\u003e Fever, nausea, or allergic-type symptoms can occur but are uncommon. No new safety signals emerged in trials; about 44,000 people across studies showed mostly mild-moderate reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePrecautions:\u003c\/strong\u003e Abrysvo should not be given to anyone with a known severe allergy to any component of the vaccine (the label suggests none of the excipients are common allergens). If a pregnant person has other routine vaccines due (e.g. Tdap), they can generally be given at separate sites or times (studies showed no interaction). Abrysvo is not a live vaccine, so it can be given safely during pregnancy (unlike some live vaccines). There is a pregnancy registry to monitor outcomes, but to date no safety issues (e.g. birth defects) were found.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e Abrysvo comes in vials that are refrigerated. It should be kept cold until use (often 2–8°C). Once reconstituted, any leftover vaccine should be used promptly and any unused portion discarded (it is preservative-free).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy get Abrysvo?\u003c\/strong\u003e RSV can cause severe illness in young infants (especially preemies) and in older or vulnerable adults. Before Abrysvo, no vaccine existed to prevent RSV. By vaccinating pregnant individuals and high-risk adults, we can reduce hospitalizations and severe disease from RSV. The vaccine does not cause RSV infection; instead, it primes the immune system against it. According to regulators, the benefits of reducing RSV illness outweigh the small risks of side effects.\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":39980447236168,"sku":"00069-0344-01","price":492.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Abrysvo-RSV-Vaccine-_Respiratory-Syncytial-Virus-Vaccine_-0.5-mL_6140b11a-b299-4dfa-a99b-f3c47a9425d9.jpg?v=1692707308"},{"product_id":"rotateq-rotavirus-vccine-live-oral-infant-baby-immunization","title":"RotaTeq Rotavirus Vaccine Live, Oral 2 mL by Merck for Infants and Babies (RX) **Refrigerated","description":"\u003cp\u003eProtect your baby from severe rotavirus gastroenteritis with RotaTeq, the leading oral rotavirus vaccine trusted by parents and pediatricians worldwide. RotaTeq by Merck is a safe, highly effective, and recommended vaccine for infants, offering reliable defense against rotavirus—the primary cause of severe diarrhea and hospitalizations in children globally.\u003c\/p\u003e\n\u003ch3\u003eKey Product Features \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Rotavirus Protection:\u003c\/strong\u003e Prevents severe diarrhea, vomiting, and dehydration caused by rotavirus infection in babies and young children.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOral, Needle-Free Vaccine:\u003c\/strong\u003e Easy administration—oral solution formulation, designed for minimal stress and maximum safety during routine immunization.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Developed by Merck, a world leader in pediatric vaccines and infectious disease prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlobally Recommended:\u003c\/strong\u003e Endorsed by the CDC, WHO, and pediatric health organizations as a key part of the infant immunization schedule.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh Efficacy:\u003c\/strong\u003e Proven to reduce hospitalizations and emergency visits due to rotavirus gastroenteritis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Dosing:\u003c\/strong\u003e Comes in 2 mL doses—perfect for clinics, pediatric offices, and vaccination centers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Health Terms for this product\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRotaTeq vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRotavirus vaccine for babies\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eInfant immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eOral vaccine for infants\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent diarrhea in babies\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBaby vaccine schedule\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRotavirus prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBest vaccine for infants\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePediatric vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC recommended baby vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSafe vaccines for newborns\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMerck vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eProtect baby from rotavirus\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eChildhood vaccine schedule\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eGastroenteritis vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eInfant health protection\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eNewborn vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent severe diarrhea infants\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for baby diarrhea\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose RotaTeq?\u003c\/h3\u003e\n\u003cp\u003eSevere rotavirus infection is a leading cause of hospitalization and dehydration in infants and young children worldwide. \u003cstrong\u003eRotaTeq\u003c\/strong\u003e is scientifically formulated to provide the most complete protection against multiple rotavirus types. As a safe, oral, live attenuated vaccine, RotaTeq is essential for keeping babies healthy, reducing the risk of severe illness, and ensuring peace of mind for families.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRotaTeq\u003c\/strong\u003e is included in routine immunization schedules, trusted by millions of parents and approved by pediatric health authorities for its safety, outstanding efficacy, and ease of use.\u003c\/p\u003e\n\u003ch3\u003eUsage \u0026amp; Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e 2 mL per oral dose\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e 3-dose series at 2, 4, and 6 months of age, per CDC guidelines\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Refrigerate until use; do not freeze\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Oral, non-injectable\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety Information\u003c\/h3\u003e\n\u003cp\u003eRotaTeq is well-tolerated by infants, with a safety profile supported by global clinical trials and millions of doses given worldwide. The most common side effects are mild and temporary, such as irritability, mild diarrhea, or vomiting. Serious allergic reactions are extremely rare. Always consult your pediatrician before beginning any vaccination.\u003c\/p\u003e\n\u003ch3\u003eOrder RotaTeq Rotavirus Vaccine Today\u003c\/h3\u003e\n\u003cp\u003eSafeguard your child’s health with \u003cstrong\u003eRotaTeq Rotavirus Vaccine Live, Oral Solution 2 mL by Merck\u003c\/strong\u003e. Ensure your clinic, hospital, or pediatric practice is prepared to meet CDC infant immunization requirements and provide the highest standard of protection against rotavirus disease.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy RotaTeq now for effective, needle-free protection—trusted for infant and baby health worldwide.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Merck","offers":[{"title":"Default Title","offer_id":40327897153608,"sku":"00006-4047-41","price":1395.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/RotaTeq-Rotavirus-Vaccine-by-Merck-for-Babies-and-Infants.jpg?v=1756385808"},{"product_id":"xembify-immune-globulin-subcutaneous-human-klhw-20-injection-5-ml-requires-refrigeration","title":"Xembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL **Requires Refrigeration","description":"\u003cp\u003eXembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL is a prescription medication used for the treatment of primary immunodeficiency (PI), a group of disorders in which the immune system is not functioning properly. It provides the body with antibodies that help to fight against infections. This medication is made from human plasma and is given as an injection under the skin (subcutaneously). It is also known as a subcutaneous immunoglobulin (SCIG) and is manufactured by Baxalta US Inc. Xembify is specifically formulated with the immune globulin klhw, which stands for kappa-free antibody in polysorbate. It is available in a 5 mL vial and contains 20% immune globulin.\u003c\/p\u003e\n\u003cp\u003eXembify Immune Globulin Subcutaneous, Human – klhw 20% (also known as Hizentra) is a medication used for replacement therapy in patients with primary immunodeficiency (PID). It is a solution of immunoglobulin G (IgG) antibodies that is injected under the skin (subcutaneously).\u003c\/p\u003e\n\u003cp\u003eIgG antibodies are a type of protein that is naturally produced by the immune system to help fight off infections. In patients with PID, their immune system does not produce enough IgG antibodies, putting them at a higher risk for infections.\u003c\/p\u003e\n\u003cp\u003eXembify works by replacing the deficient IgG antibodies in patients with PID. This helps to boost their immune system and protect them against infections. The IgG antibodies in Xembify are extracted from healthy human blood donors and purified to remove any potential impurities.\u003c\/p\u003e\n\u003cp\u003eOnce injected under the skin, Xembify is absorbed into the bloodstream and circulates throughout the body, providing protection against a wide range of bacteria, viruses, and other pathogens. It also helps to reduce the frequency and severity of infections in patients with PID.\u003c\/p\u003e\n\u003cp\u003eOverall, Xembify works to help improve and maintain the immune function of patients with PID. It is an important form of therapy that can greatly benefit these individuals and help them lead healthier lives.\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"Default Title","offer_id":40342539206728,"sku":"13533-0810-05","price":375.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Immune-Globulin-Treatments.jpg?v=1719923262"},{"product_id":"gamastan-immune-globulin-15-18-single-dose-vial-2-ml-requires-refrigeration-rx","title":"GamaSTAN Immune Globulin (Human) Treatment Single-Dose Vial * Refrigerated (RX)","description":"\u003ch3\u003eProven Passive Immunity for Hepatitis A, Measles, Rubella, and Varicella Exposure\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTrusted Protection, Fast Immunity—FDA-Approved Human Immune Globulin for Post-Exposure Prophylaxis\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003eWhen rapid, targeted immunological support is essential, medical professionals turn to \u003cstrong\u003eGamaSTAN Immune Globulin (Human) Treatment\u003c\/strong\u003e by Grifols Therapeutics. Developed to deliver immediate, passive antibody protection, GamaSTAN is the gold standard for post-exposure prophylaxis against \u003cstrong\u003eHepatitis A\u003c\/strong\u003e, \u003cstrong\u003eMeasles (Rubeola)\u003c\/strong\u003e, \u003cstrong\u003eRubella\u003c\/strong\u003e, and \u003cstrong\u003eVaricella (chickenpox)\u003c\/strong\u003e. Available in a convenient, premeasured \u003cstrong\u003esingle-dose vial\u003c\/strong\u003e, this injectable solution is carefully purified from human plasma and manufactured to the highest safety and efficacy standards.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eClinical Applications:\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eGamaSTAN Immune Globulin\u003c\/strong\u003e is a trusted, FDA-approved solution for healthcare professionals seeking to provide:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-Exposure Prophylaxis (PEP):\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatitis A\u003c\/strong\u003e: For susceptible individuals exposed to Hepatitis A virus (HAV)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMeasles\u003c\/strong\u003e: For non-immune individuals exposed to confirmed measles (rubeola) cases\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVaricella (Chickenpox)\u003c\/strong\u003e: For high-risk individuals exposed to varicella-zoster virus\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRubella\u003c\/strong\u003e: For immediate passive protection where rubella risk is high and vaccination is contraindicated\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTemporary Immune Support\u003c\/strong\u003e for immunocompromised patients unable to mount an adequate vaccine response\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProtection for International Travelers\u003c\/strong\u003e: Guarding against prevalent infectious diseases in high-risk areas\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eGamaSTAN\u003c\/strong\u003e delivers \u003cstrong\u003ehuman immune globulin\u003c\/strong\u003e with a proven efficacy and safety profile. As a plasma-derived medication, it supplies IgG antibodies to bridge the gap until the recipient’s immune system can respond or until vaccination becomes effective.\u003c\/p\u003e\n\u003ch3\u003eFeatures \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmediate Passive Immunity:\u003c\/strong\u003e Provides rapid-acting immunoglobulin (IgG) antibodies for immediate post-exposure protection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA-Approved for Multiple Indications:\u003c\/strong\u003e Indicated for prophylaxis and protection following exposure to Hepatitis A virus, Measles, Rubella, and Varicella.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-Dose, Ready-to-Use Vial:\u003c\/strong\u003e Ensures precise dosing, reduces waste, and supports safe administration in hospital, clinic, or travel medicine settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurified Human Immune Globulin:\u003c\/strong\u003e Manufactured from carefully screened donors, virus-inactivation and removal processes ensure product safety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted by Physicians and Hospitals:\u003c\/strong\u003e Backed by Grifols Therapeutics—a global leader in immunotherapy and plasma protein therapeutics.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDirections for Use\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e For intramuscular injection only. Dosage depends on indication, patient body weight, and risk assessment. Refer to the prescribing information for detailed dosing guidelines.\u003c\/li\u003e\n\u003cli\u003eFor optimal protection, administer as soon as possible after exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProfessional Use Only:\u003c\/strong\u003e For use by or under the supervision of a healthcare professional.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose GamaSTAN Immune Globulin by Grifols?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eFDA-approved for multiple, life-threatening viral exposures\u003c\/li\u003e\n\u003cli\u003eFast-acting solution for urgent healthcare and public health needs\u003c\/li\u003e\n\u003cli\u003eManufactured using advanced purification and viral inactivation processes\u003c\/li\u003e\n\u003cli\u003ePrecise single-dose vials for reliable, controlled administration\u003c\/li\u003e\n\u003cli\u003eWidely used and trusted in hospitals, clinics, and travel medicine practices\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eImportant Safety Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eContraindications:\u003c\/strong\u003e Do not use in individuals with known severe allergic reactions to human immunoglobulins.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCautions:\u003c\/strong\u003e Use with care in patients with IgA deficiency or a history of anaphylaxis to immunoglobulins.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSide Effects:\u003c\/strong\u003e Rarely, may include injection site reactions, headache, fever, or allergic reactions.\u003c\/li\u003e\n\u003cli\u003eMonitor patients as per clinical guidelines when administering any biologic product.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eOrder Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePresentation:\u003c\/strong\u003e Single-dose vial for intramuscular injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Grifols Therapeutics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003e\u003cstrong\u003eProtect your patients and community with the gold standard in passive immunity—GamaSTAN Immune Globulin (Human) Treatment by Grifols Therapeutics. Ensure immediate antibody protection for Hepatitis A, Measles, Varicella, and Rubella today.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"2 mL Vial","offer_id":40342564765768,"sku":"13533-0335-04","price":225.0,"currency_code":"USD","in_stock":true},{"title":"10 mL Vial","offer_id":40342564798536,"sku":"13533-0335-12","price":850.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/GamaSTAN-Immune-Globulin-Human-Treatment.jpg?v=1766423161"},{"product_id":"prevar-20-pneumococcal-20-valent-conjugate-vaccine-diphtheria-crm197-protein","title":"Prevnar 20 Vaccine Pneumococcal 20-valent Conjugate (Diphtheria CRM197 Protein) 0.5 mL x 10\/Pack Pfizer USPG **Refrigerated (RX)","description":"\u003cp\u003eProtect your patients against 20 strains of invasive pneumococcal disease with Prevnar 20—the latest advancement in pneumococcal immunization from Pfizer. Trusted by healthcare professionals, Prevnar 20 delivers comprehensive, broad-spectrum protection for adults and children, helping prevent pneumonia, bloodstream infections, and meningitis caused by Streptococcus pneumoniae.\u003c\/p\u003e\n\u003ch3\u003eProduct Features \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroadest Pneumococcal Coverage:\u003c\/strong\u003e The only FDA-approved 20-valent conjugate vaccine, targeting 20 pneumococcal serotypes responsible for the majority of invasive infections.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvanced Conjugate Technology:\u003c\/strong\u003e Utilizes Diphtheria CRM197 protein carrier to stimulate a strong, lasting immune response.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Developed by Pfizer USPG, a global leader in vaccines and infection prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVersatile Indications:\u003c\/strong\u003e Approved for use in adults 18+ and pediatric patients as indicated by the CDC.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReady-to-Use Dosing:\u003c\/strong\u003e Available in convenient, single-dose prefilled syringes for easy administration in hospitals, clinics, and long-term care settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCDC and ACIP Recommended:\u003c\/strong\u003e Aligned with current immunization guidelines for adult and childhood pneumococcal vaccination schedules.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Health-Related Searched Terms:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003ePrevnar 20 vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePneumococcal conjugate vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e20-valent pneumonia vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePneumonia prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdult immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSenior vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC recommended vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eChildhood vaccination\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePneumonia vaccine for adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePfizer vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccines for seniors over 65\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunization for chronic disease\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRespiratory infection prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFDA approved vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTravel vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevention of bacterial pneumonia\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePneumococcal disease protection\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eLong-term care vaccination\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Prevnar 20?\u003c\/h3\u003e\n\u003cp\u003ePneumococcal infections are a leading cause of morbidity and mortality, especially in adults over 65, those with chronic diseases, and young children. \u003cstrong\u003ePrevnar 20\u003c\/strong\u003e offers the highest valency available in pneumococcal conjugate vaccines, increasing immunity against more serotypes than ever before.\u003c\/p\u003e\n\u003cp\u003eWhether you’re aiming to fulfill the \u003cstrong\u003eadult or senior pneumonia vaccine recommendations\u003c\/strong\u003e, protect high-risk populations from invasive \u003cem\u003eStreptococcus pneumoniae\u003c\/em\u003e infections, or support robust immunity in pediatric and immunocompromised patients, \u003cstrong\u003ePrevnar 20 by Pfizer\u003c\/strong\u003e sets a new standard for preventive healthcare.\u003c\/p\u003e\n\u003ch3\u003eAdministration \u0026amp; Dosage\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e 0.5 mL intramuscular injection (single-dose vial or prefilled syringe)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAge Indication:\u003c\/strong\u003e Adults 18 years and older; children per CDC guidelines\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing Schedule:\u003c\/strong\u003e Single-dose for most adults; consult CDC guidelines for pediatric series or catch-up immunizations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety \u0026amp; Side Effects\u003c\/h3\u003e\n\u003cp\u003ePrevnar 20 is well-tolerated, with side effects usually mild to moderate and transient. The most common include injection site pain, redness, swelling, muscle aches, fatigue, headache, and mild fever. Serious allergic reactions are rare. Consult a healthcare provider regarding medical history and potential contraindications.\u003c\/p\u003e\n\u003ch3\u003eOrder Prevnar 20 Vaccine Today\u003c\/h3\u003e\n\u003cp\u003eEnhance your immunization program with \u003cstrong\u003ePrevnar 20 Pneumococcal 20-valent Conjugate Vaccine by Pfizer USPG\u003c\/strong\u003e—the most comprehensive pneumococcal vaccine available. Stock up and protect adults and children against the full spectrum of serious pneumococcal diseases.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Prevnar 20 now for broad-spectrum protection, effective pneumonia prevention, and the latest in vaccine technology—trusted for adult, senior, and pediatric immunization worldwide.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":40352071778376,"sku":"00005-2000-10","price":3650.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Prevnar-20-Vaccine-Pneumococcal-20-valent-Conjugate-Diphtheria-CRM197-Protein.jpg?v=1756384486"},{"product_id":"ribavirin-tablets-200-mg-by-aurobindo","title":"Ribavirin Tablets 200 mg by Aurobindo 168 Count (RX)","description":"\u003cp\u003eRibavirin Tablets 200 mg are an antiviral medication used in combination with other medications to treat chronic hepatitis C infection. It works by stopping the virus from multiplying and infecting new cells in the body. This medication may also be used to treat severe respiratory syncytial virus (RSV) infection in children. It should always be used under the guidance of a healthcare professional.\u003c\/p\u003e\n\u003cp\u003eRibavirin Tablets 200 mg are a prescription medication used in the treatment of hepatitis C virus, a liver infection. They contain the active ingredient ribavirin, which works by stopping the virus from multiplying and spreading in the body.\u003c\/p\u003e\n\u003cp\u003eThese tablets are typically used in combination with other medications, such as interferon or sofosbuvir, to increase the success rate of treatment. Together, these drugs work to eradicate the hepatitis C virus from the body, preventing it from causing liver damage and other complications.\u003c\/p\u003e\n\u003cp\u003eRibavirin Tablets 200 mg are available in both brand-name and generic forms, and they are only available with a doctor's prescription. They should be taken exactly as directed by a healthcare provider, and treatment often lasts for several weeks or months depending on the specific treatment plan. \u003c\/p\u003e\n\u003c!----\u003e","brand":"Aurobindo Pharma USA","offers":[{"title":"Default Title","offer_id":40373345189960,"sku":"65862-0207-68","price":179.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Ribavirin-Tablets-200-mg-by-Aurobindo-168-Count-by-Aurobindo-Pharma.jpg?v=1724692296"},{"product_id":"boostrix-dpt-vaccine","title":"Boostrix DPT Vaccine Prefilled Syringes 0.5 mL x 10\/Box GSK Vaccine for Adults \u0026 Children (RX) **Refrigerated","description":"\u003cp\u003eProtect your patients from whooping cough, diphtheria, and tetanus with Boostrix DPT Vaccine by GSK—a leading solution for comprehensive and reliable immunization. This vaccine is recommended by the CDC and trusted globally to ensure lasting immunity in adolescents, adults, and expectant mothers.\u003c\/p\u003e\n\u003cp\u003eBoostrix DPT Vaccine is a combined immunization product designed to protect individuals from three serious bacterial infections: Diphtheria, Pertussis (whooping cough), and Tetanus. This vaccine is typically administered as part of childhood immunization schedules and booster doses for adolescents and adults. It is conveniently supplied in prefilled syringes, ensuring precise dosing and ease of administration for healthcare providers.\u003c\/p\u003e\n\u003ch3\u003eProduct Highlights\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTriple Protection:\u003c\/strong\u003e Defends against Diphtheria, Tetanus, and Pertussis (whooping cough)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePremium Quality:\u003c\/strong\u003e Developed by GSK (GlaxoSmithKline), a world leader in vaccine innovation and safety\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePre-filled Convenience:\u003c\/strong\u003e 10 prefilled 0.5 mL syringes per box—ideal for clinics, hospitals, and vaccination campaigns\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCDC Recommended:\u003c\/strong\u003e Essential for adolescent and adult booster doses, including pregnant women for maternal and newborn protection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid Immunization:\u003c\/strong\u003e Easy administration with single-dose, prefilled syringes for streamlined workflow in healthcare settings\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProven Efficacy \u0026amp; Safety:\u003c\/strong\u003e Backed by extensive clinical trials, FDA approval, and post-marketing surveillance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Health-Related Searched Terms\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eDPT vaccine\u003c\/li\u003e\n\u003cli\u003eTdap booster shot\u003c\/li\u003e\n\u003cli\u003eWhooping cough vaccine\u003c\/li\u003e\n\u003cli\u003eAdult pertussis vaccine\u003c\/li\u003e\n\u003cli\u003eDiphtheria tetanus pertussis vaccine\u003c\/li\u003e\n\u003cli\u003eCDC vaccine recommendations\u003c\/li\u003e\n\u003cli\u003eImmunization for adults\u003c\/li\u003e\n\u003cli\u003eChildhood vaccination schedule\u003c\/li\u003e\n\u003cli\u003ePregnancy Tdap vaccine\u003c\/li\u003e\n\u003cli\u003eTetanus booster\u003c\/li\u003e\n\u003cli\u003eSchool vaccine requirements\u003c\/li\u003e\n\u003cli\u003eTravel vaccines\u003c\/li\u003e\n\u003cli\u003eFDA approved vaccines\u003c\/li\u003e\n\u003cli\u003eSafe vaccines for pregnancy\u003c\/li\u003e\n\u003cli\u003eInjection for whooping cough\u003c\/li\u003e\n\u003cli\u003ePreventive healthcare vaccine\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Boostrix (Tdap)?\u003c\/h3\u003e\n\u003cp\u003eWhooping cough (pertussis), diphtheria, and tetanus are serious, potentially life-threatening diseases that continue to pose significant health risks, especially for infants, adolescents, and adults with waning immunity. \u003cstrong\u003eBoostrix\u003c\/strong\u003e is recommended for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdolescents as part of routine booster immunization\u003c\/li\u003e\n\u003cli\u003eAdults requiring booster protection\u003c\/li\u003e\n\u003cli\u003ePregnant women to protect newborns against pertussis\u003c\/li\u003e\n\u003cli\u003eHealthcare workers, caregivers, and travelers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRegular vaccination with \u003cstrong\u003eBoostrix\u003c\/strong\u003e is crucial to uphold personal health, fulfill school and employment requirements, and protect vulnerable populations through community immunity.\u003c\/p\u003e\n\u003ch3\u003eUsage \u0026amp; Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e 0.5 mL per dose\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e 10 prefilled syringes per box\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute:\u003c\/strong\u003e Intramuscular injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e Single-dose booster; follow CDC guidelines for timing and eligibility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety Information\u003c\/h3\u003e\n\u003cp\u003eBoostrix has a strong safety profile. The most common side effects are mild and temporary, including injection site pain, swelling, headache, fatigue, or mild fever. Severe allergic reactions are rare. Always inform your healthcare professional of any allergies or prior adverse reactions to vaccines.\u003c\/p\u003e\n\u003ch3\u003eOrder Boostrix Online Today\u003c\/h3\u003e\n\u003cp\u003eMaximize protection and meet national immunization guidelines with Boostrix DPT Vaccine Prefilled Syringes by GSK. Stock this essential vaccine to ensure readiness for routine and catch-up immunization in your healthcare facility.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Boostrix now for fast, effective, and reliable protection against diphtheria, tetanus, and whooping cough—trusted by healthcare professionals worldwide.\u003c\/strong\u003e\u003c\/p\u003e","brand":"GSK Vaccine","offers":[{"title":"Default Title","offer_id":40391131005000,"sku":"58160-0842-52","price":699.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Boostrix-DPT-Vaccine-by-GSK-Vaccines-NDC-58160-0842-52.jpg?v=1736962382"},{"product_id":"panzyga-10-2500-mg-immune-globulin-subcutaneous-human-ifas-10-solution-25-ml","title":"Panzyga 10% (2500 mg) (Immune Globulin Subcutaneous (Human)-ifas, 10% Solution) 25 mL","description":"\u003cp\u003ePanzyga 10% (2500 mg) is an intravenous immune globulin therapy used to manage immune deficiencies and autoimmune conditions. It is primarily prescribed for primary immunodeficiency (PI), where it provides essential antibodies to enhance the immune response and prevent infections. Additionally, Panzyga is used for treating chronic inflammatory demyelinating polyneuropathy (CIDP), helping to improve muscle strength and mobility by modulating immune system activity. The treatment is pivotal in supporting patients with compromised immune functions and reducing the frequency and severity of infections.\u003c\/p\u003e\n\u003cp\u003ePanzyga 10% (2500 mg) Immune Globulin Subcutaneous (Human) is used for the treatment of primary immunodeficiency (PI), boosting the immune system by providing necessary antibodies. It is also effective for chronic inflammatory demyelinating polyneuropathy (CIDP), helping to alleviate symptoms and improve muscle strength. Panzyga works by replacing or supplementing antibodies in patients with antibody deficiencies, thus offering protection against infections and supporting immune system function..\u003c\/p\u003e\n\u003cp\u003ePanzyga 10% is a premium intravenous immunoglobulin (IVIG) therapy proudly presented by Octapharma. Intended for patients with compromised immune systems, Panzyga 10% provides critical passive immunity that helps to fight against infections. This innovative treatment comes in a 25 mL vial containing 2500 mg of purified immune globulin for subcutaneous or intravenous administration. Sourced from healthy human plasma, Panzyga 10% conforms to impeccable standards of safety and effectiveness, fortifying patients’ immune defense with unmatched reliability.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eConcentration:\u003c\/strong\u003e 10% Immunoglobulin G (IgG) solution\u003cbr\u003e\u003cstrong\u003eDosage Form: \u003c\/strong\u003e2500 mg in 25 mL (equivalent to 10% solution)\u003cbr\u003e\u003cstrong\u003eAdministration:\u003c\/strong\u003e Intravenous (IV) or Subcutaneous (SC)\u003cbr\u003e\u003cstrong\u003eSource: \u003c\/strong\u003eHuman plasma\u003cbr\u003e\u003cstrong\u003ePurity: \u003c\/strong\u003eMaximum removal of IgA, less than 50 mcg\/mL\u003cbr\u003e\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Octapharma, a leader in plasma derivatives\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePanzyga functions by delivering a high concentration of Immunoglobulin G (IgG) antibodies, collected from the plasma of healthy donors, directly into the patient's circulation. These antibodies are broad-spectrum in their ability to neutralize pathogens such as bacteria and viruses, as well as modulating the immune response, providing its therapeutic effect in a variety of conditions like primary immunodeficiencies and autoimmune disorders. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Administration:\u003c\/strong\u003e Panzyga 10% can be administered intravenously or subcutaneously, depending on the indication and patient need. \u003cbr\u003e\u003cstrong\u003e2. Dosing:\u003c\/strong\u003e Dosage should be individualized based on patient condition, weight, and clinical response. \u003cbr\u003e\u003cstrong\u003e3. Preparation:\u003c\/strong\u003e Visually inspect for particulate matter and discoloration. Do not shake.\u003cbr\u003e\u003cstrong\u003e4. Infusion Rate:\u003c\/strong\u003e Begin at a slow rate with a gradual increase contingent upon patient tolerance.\u003c\/p\u003e\n\u003cp\u003eConsult healthcare professional guidelines for precise administration protocol.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Be aware of potential allergic reactions; contraindicated in individuals with known hypersensitivity to immunoglobulin preparations.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood Glucose Monitoring:\u003c\/strong\u003e This product may affect measurements; specifically use monitoring systems PCA or PDMS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Dysfunction:\u003c\/strong\u003e Monitor renal function; cases of renal failure have been reported.\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThrombosis:\u003c\/strong\u003e Exercise caution for individuals with a history of thrombosis. Ensure adequate hydration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eCommon side effects may include:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMild to moderate headache\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFatigue and fever\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eInfusion site reactions like redness or swelling\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eNausea\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHypertension\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRare but serious reactions might include:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAnaphylaxis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eThromboembolic events\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHemolytic anemia\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAcute renal failure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e Disclaimer\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis information serves as a summary of the essential aspects regarding the administration and potential impact of Panzyga 10%. Comprehensive prescribing information, direction from healthcare professionals, and personalized patient assessments are necessary to optimize the safe and effective use of Panzyga 10%.\u003c\/p\u003e","brand":"Octapharma USA","offers":[{"title":"Default Title","offer_id":51678771347824,"sku":"68982-0822-02","price":799.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Panzyga-10_-by-Pfizer.jpg?v=1731594400"},{"product_id":"trumenba-meningococcal-vaccine-group-b-injection","title":"Trumenba Meningococcal Vaccine Group B Injection 0.5 mL x 5\/Box Pfizer **Refrigerated","description":"\u003cp\u003eSafeguard against life-threatening meningococcal disease with Trumenba Meningococcal Vaccine Group B. This prescription vaccine is expertly formulated and manufactured by Pfizer, a global leader in preventive healthcare and immunizations. Trumenba provides powerful protection against invasive meningococcal group B (MenB) infections, recommended for adolescents, young adults, and individuals at increased risk of meningococcal disease.\u003c\/p\u003e\n\u003ch3\u003eKey Features \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Protection:\u003c\/strong\u003e Trumenba targets Neisseria meningitidis serogroup B, preventing meningitis and septicemia.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrescription Vaccine:\u003c\/strong\u003e Indicated for individuals 10 to 25 years of age, especially those at heightened risk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Pfizer USPG, known for stringent quality controls and research-backed vaccines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Packaging:\u003c\/strong\u003e Each box contains 5 pre-filled 0.5 mL single-dose syringes, ideal for clinics, hospitals, and healthcare providers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProven Immunogenicity:\u003c\/strong\u003e Produces a robust immune response, as demonstrated in clinical trials and post-marketing surveillance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Searched Health Keywords for this product.\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eMeningococcal Vaccination\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMenB Vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMeningitis Prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for Adolescents\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eChildhood Immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCollege Vaccine Requirements\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eInfection Control\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC Recommended Vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevention of Bacterial Meningitis\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunity Boost\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePediatric Vaccine Schedule\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHighly Effective Vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSafe Vaccines for Teens\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eUS FDA Approved Vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eDisease Outbreak Prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Trumenba?\u003c\/h3\u003e\n\u003cp\u003eMeningococcal group B infections can progress rapidly and may be fatal or result in serious long-term health complications. Trumenba is strongly recommended by the CDC and other leading health organizations for those entering crowded settings such as college campuses or military barracks, and for anyone with underlying health conditions that increase risk. Timely immunization is crucial for ultimate protection and public health safety.\u003c\/p\u003e\n\u003ch3\u003eUsage \u0026amp; Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e Intramuscular injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrength:\u003c\/strong\u003e 0.5 mL per pre-filled syringe\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNumber of Doses:\u003c\/strong\u003e 5 syringes per box\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e Typically administered as a two- or three-dose series depending on age and risk factors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety \u0026amp; Side Effects\u003c\/h3\u003e\n\u003cp\u003eTrumenba is generally well-tolerated. Common side effects may include injection-site pain, mild swelling, redness, headache, fatigue, muscle pain, or fever. Serious adverse reactions are extremely rare. Always consult a healthcare provider regarding individual health conditions and vaccination suitability.\u003c\/p\u003e\n\u003ch3\u003eOrder Now for Advanced Disease Prevention\u003c\/h3\u003e\n\u003cp\u003eEnsure comprehensive immunization and meet state or institutional requirements with Trumenba Meningococcal Vaccine Group B Injection Suspension by Pfizer USPG. Stock up on this essential vaccine to protect individuals in your care against serious meningococcal disease and boost your infection prevention protocols.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Trumenba MenB Vaccine now — trusted protection for adolescents and young adults against meningococcal meningitis and bloodstream infections.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":52203705729392,"sku":"00005-0100-05","price":1550.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Trumenba-Meningococcal-Vaccine.jpg?v=1745257137"},{"product_id":"ixiaro-japanese-encephalitis-vaccine","title":"Japanese Encephalitis Vaccine 0.5 mL Syringe 6 mcg IXIARO (RX)","description":"\u003cp\u003eIXIARO is a vaccine used to prevent Japanese encephalitis, a viral infection transmitted by mosquitoes. It's primarily recommended for travelers or residents in regions where the disease is common, such as parts of Asia and the Western Pacific. The vaccine stimulates the immune system to produce antibodies against the Japanese encephalitis virus, offering protection against the disease. It's typically given in two doses, with a booster recommended for ongoing or repeated exposure. Always consult with a healthcare provider to determine if IXIARO is appropriate based on travel plans and risk factors.\u003c\/p\u003e\n\u003cp data-pm-slice=\"1 1 []\"\u003e\u003cstrong\u003eWho needs the IXIARO Japanese Encephalitis Vaccine\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIXIARO is a vaccine designed to protect against Japanese Encephalitis (JE), a potentially severe viral infection transmitted by mosquitoes. It is particularly relevant for the following groups:\u003c\/p\u003e\n\u003cp\u003e1. \u003cstrong\u003eTravelers\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegion:\u003c\/strong\u003e Individuals traveling to areas where Japanese Encephalitis is common, primarily in rural parts of Asia and the western Pacific.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Particularly those who plan to stay for long periods or engage in outdoor activities in endemic areas.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2. \u003cstrong\u003eMilitary Personnel\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStationed in endemic regions where the risk of exposure to the JE virus is higher.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e3. \u003cstrong\u003eExpatriates\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePeople moving to or living in areas with known risks of JE transmission.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e4. \u003cstrong\u003eLaboratory Workers\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThose who might be exposed to the JE virus in a lab setting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e5. \u003cstrong\u003eResidents of Endemic Areas\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eIn certain cases, residents in endemic regions, especially during outbreaks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eConsiderations\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eVaccination Schedule:\u003c\/strong\u003e Typically involves two doses, administered 28 days apart.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsultation:\u003c\/strong\u003e Individuals should consult healthcare providers for advice tailored to their specific travel plans and health conditions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIXIARO provides crucial protection for those at risk of exposure to the Japanese Encephalitis virus, helping prevent serious health outcomes.\u003c\/p\u003e","brand":"Valneva USA","offers":[{"title":"Default Title","offer_id":52205041156464,"sku":"42515-0002-01","price":525.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Japanese-Encephalitis-Vaccine-0.5-mL-Syringe.jpg?v=1745324468"},{"product_id":"engerix-b-hepatitis-b-vaccine-syringe-0-5-ml-infants-babies-adults","title":"Engerix B Hepatitis B Vaccine Syringe for Infants, Babies \u0026 Adults, GSK Vaccines 0.5 mL x 10\/Box (Rx) * Refrigerated","description":"\u003ch2\u003eEngerix B Hepatitis B Vaccine Syringe by GSK Vaccines – Safe, Effective \u0026amp; Proven Immunization\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eProtect your health and the health of your loved ones with the\u003c\/strong\u003e \u003cstrong\u003eEngerix B Hepatitis B Vaccine Syringe by GSK Vaccines\u003c\/strong\u003e—the leading choice for safe, effective, and highly reliable hepatitis B immunization. Developed by GlaxoSmithKline (GSK), a global leader in vaccine innovation, this vaccine delivers advanced, clinically proven protection against hepatitis B virus (HBV), a major cause of acute and chronic liver disease worldwide.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e*** This item requires refrigeration ***\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eWhy Choose Engerix B Hepatitis B Vaccine?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnmatched Protection\u003c\/strong\u003e: Proven to provide robust hepatitis B immunity and recognized globally for its superior efficacy and long-lasting defense against HBV infection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid Immune Response\u003c\/strong\u003e: Engineered for fast and comprehensive seroprotection, ensuring high antibody levels for children, adults, and high-risk groups.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSafe for All Ages\u003c\/strong\u003e: Approved for administration in infants, children, adolescents, and adults, including healthcare workers, travelers, patients with chronic conditions, and immuno-compromised individuals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Pre-filled Syringe\u003c\/strong\u003e: Each sterile dose is ready for immediate use, minimizing the risk of contamination and dosing errors.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMinimal Side Effects\u003c\/strong\u003e: Extensively tested for safety and well tolerated with only mild, temporary side effects such as redness, swelling, or mild fever.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eProduct Features \u0026amp; Top Health Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Hepatitis B Protection:\u003c\/strong\u003e Effectively prevents hepatitis B virus (HBV) infection, liver disease, and complications in all age groups.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAll-Age Immunization:\u003c\/strong\u003e Approved for newborns, infants, children, adolescents, and adults, including high-risk populations and healthcare workers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Produced by GSK Vaccines, a global leader in vaccine innovation and safety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReady-to-Use Syringes:\u003c\/strong\u003e Contains 10 prefilled 0.5 mL syringes per box for seamless administration in clinics, hospitals, and pediatric practices.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCDC \u0026amp; WHO Recommended:\u003c\/strong\u003e Meets strict vaccine schedule requirements, including for newborns and at-risk adults.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSafe and Well-Tolerated:\u003c\/strong\u003e Rigorous clinical trials confirm high efficacy and an excellent safety profile.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMeets School \u0026amp; Travel Requirements:\u003c\/strong\u003e Fulfills immunization mandates for schools, colleges, and international travel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Engerix-B Hepatitis B Vaccine by GSK?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHepatitis B is a highly contagious liver infection that can lead to chronic disease, cirrhosis, and liver cancer.\u003c\/strong\u003e The CDC and WHO recommend hepatitis B vaccination at birth and for all unvaccinated children and at-risk adults. Engerix-B provides proven, lasting immunity from the start of life through adulthood, making it a key part of every immunization program and travel health plan.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cem\u003e\u003cstrong\u003eEssential newborn vaccine\u003c\/strong\u003e\u003c\/em\u003e for immediate protection after birth\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e\u003cstrong\u003eCrucial for healthcare professionals, travelers, and high-risk groups\u003c\/strong\u003e\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e\u003cstrong\u003ePrevents life-threatening complications with a trusted, safe formula\u003c\/strong\u003e\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003e\u003cstrong\u003eComplies with all global and US hepatitis B vaccine requirements\u003c\/strong\u003e\u003c\/em\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eVaccine Schedule:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfants:\u003c\/strong\u003e Birth, 1-2 months, 6-18 months\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren\/Adolescents:\u003c\/strong\u003e 0, 1-2, and 6-18 months apart\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults:\u003c\/strong\u003e 0, 1, and 6 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfants and Children (up to 19 years):\u003c\/strong\u003e 0.5 mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults (20 years and older):\u003c\/strong\u003e 1.0 mL (not in this product specification)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDirections for Use\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e 0.5 mL single-dose prefilled syringe\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e 10 syringes per box\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e Series of 3–4 doses per CDC infant, child, and adult immunization guidelines\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Intramuscular injection by qualified healthcare providers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety \u0026amp; Side Effects\u003c\/h3\u003e\n\u003cp\u003eEngerix-B is extensively studied and well-tolerated. Common, mild side effects include redness, tenderness at the injection site, slight fever, and fatigue. Severe reactions are very rare. Consult your healthcare provider if you have allergies or concerns regarding vaccination.\u003c\/p\u003e\n\u003ch3\u003eFrequently Asked Questions\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eWho should receive Engerix B?\u003c\/strong\u003e All infants at birth, unvaccinated children, adolescents, adults at risk (including healthcare workers, travelers, and those with liver or kidney diseases), and anyone seeking reliable hepatitis B protection.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs this vaccine WHO and CDC recommended?\u003c\/strong\u003e YES, Engerix B meets all World Health Organization (WHO) and Centers for Disease Control (CDC) guidelines for routine hepatitis B vaccination.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAre there any contraindications?\u003c\/strong\u003e Do not use if allergic to yeast or any vaccine component. Always consult your healthcare provider before immunization.\u003c\/p\u003e\n\u003ch3\u003eOrder Engerix B Hepatitis B Vaccine Syringe by GSK Vaccines Today!\u003c\/h3\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eMaximize your liver health and prevent hepatitis B for life. Trust Engerix B, the world’s most prescribed hepatitis B vaccine syringe—safe, effective, and recommended by healthcare professionals across the globe!\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Engerix-B now for reliable protection against hepatitis B—trusted by healthcare professionals and families worldwide.\u003c\/strong\u003e\u003c\/p\u003e","brand":"GSK Vaccines","offers":[{"title":"Default Title","offer_id":52208594223472,"sku":"58160-0820-52","price":495.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Engerix-B-Hepatitis-B-Vaccine-Syringe-0.5-mL.jpg?v=1758629695"},{"product_id":"recombivax-hb-hepatitis-b-vaccine-syringes-0-5-ml-x-10-box","title":"Recombivax HB Hepatitis B Vaccine Syringes 0.5 mL x 10\/Box","description":"\u003cp\u003eIntroducing Recombivax HB Hepatitis B Vaccine by Merck, a trusted solution for effective immunization against the hepatitis B virus. Each 0.5 mL prefilled syringe is designed for precise administration, ensuring maximum protection. Packaged in a convenient box of 10 syringes, Recombivax HB is ideal for healthcare providers focused on safeguarding patients from hepatitis B.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eVaccine Schedule:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfants:\u003c\/strong\u003e Birth, 1-2 months, 6-18 months\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren\/Adolescents:\u003c\/strong\u003e 0, 1-2, and 6-18 months apart\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults:\u003c\/strong\u003e 0, 1, and 6 months (alternative schedules available for specific groups)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInfants and Children (up to 19 years):\u003c\/strong\u003e 0.5 mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults (20 years and older):\u003c\/strong\u003e 1.0 mL (not in this product specification)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCDC Guidelines:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eRecommended for all infants, unimmunized children, and at-risk adults.\u003c\/li\u003e\n\u003cli\u003eEssential for healthcare workers, travelers to high-risk regions, and individuals with chronic health conditions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eProven Protection:\u003c\/strong\u003e Effectively prevents hepatitis B infection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLong-lasting Immunity:\u003c\/strong\u003e Provides enduring immune defense.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenient Supply:\u003c\/strong\u003e Box of 10 syringes suited for clinical use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eFeatures:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrefilled Syringe:\u003c\/strong\u003e Ensures dose accuracy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e0.5 mL Dose:\u003c\/strong\u003e Tailored for infant and pediatric use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLeading Manufacturer:\u003c\/strong\u003e Developed by Merck, a leader in vaccine technology.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eUses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRecombivax HB is used for preventing hepatitis B virus infection in infants, children, and adults, supporting public health initiatives and individual health.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe vaccine contains recombinant hepatitis B surface antigen (HBsAg) that stimulates the immune system to produce antibodies, providing protective immunity.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Intramuscular injection (preferably in the anterolateral thigh for infants or the deltoid muscle for children\/adults).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDo not administer to individuals with known hypersensitivity to yeast or any other vaccine component.\u003c\/li\u003e\n\u003cli\u003eCaution advised for individuals with latex allergies (verify packaging contents).\u003c\/li\u003e\n\u003cli\u003eEnsure emergency medical solutions, such as epinephrine, are accessible for potential anaphylactic reactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection site reactions:\u003c\/strong\u003e Pain, redness, swelling\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSystemic reactions:\u003c\/strong\u003e Fatigue, fever, headache\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects are rare but can include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSevere allergic reactions:\u003c\/strong\u003e Immediate medical intervention necessary\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeurological issues:\u003c\/strong\u003e Such as Guillain-Barre syndrome (extremely rare)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eConsult a healthcare professional for advice or if serious side effects arise.\u003c\/p\u003e","brand":"Merck","offers":[{"title":"Default Title","offer_id":52208727425392,"sku":"00006-4093-02","price":450.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Recombivax-HB-Hepatitis-B-Vaccine-Syringes.jpg?v=1745505485"},{"product_id":"hyperrab-rabies-vaccine-immune-globulin-injection-rapid-rabies-protection","title":"HyperRAB Rabies Vaccine Immune Globulin Injection Dosage Vial 1 mL (300 Units) (RX)","description":"\u003cp\u003eHyperRAB Rabies vaccine Immune Globulin Injection is a sterile solution containing human antibodies specifically targeted against the rabies virus. It is used as part of post-exposure prophylaxis for individuals who have potentially been exposed to rabies, such as through an animal bite or scratch, and who have not previously been vaccinated against rabies. HyperRAB Rabies vaccine provides immediate, but temporary, passive immunity by supplying ready-made antibodies that help neutralize the virus until the person’s own immune system can respond to the rabies vaccine, which is administered at the same time. The medication is given by infiltrating as much of the dose as possible into and around the wound, while any remaining amount is injected into a muscle away from the site where the rabies vaccine is given. HyperRAB Rabies vaccine is used only once at the beginning of rabies post-exposure treatment and should always be combined with a rabies vaccine for full protection. Common side effects may include soreness at the injection site, mild fever, or headache, while serious allergic reactions are rare.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003e\u003cstrong\u003eHyperRAB\u003c\/strong\u003e is a high-potency rabies immune globulin (Human) formulated for immediate, short-term passive immunization against the rabies virus following suspected exposure. This solution contains 300 International Units (IU) per 1 mL, designed for precise and effective administration in rabies post-exposure prophylaxis (PEP).\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eWhat It Is Used For\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHyperRAB\u003c\/strong\u003e is indicated for individuals who have been exposed, or potentially exposed, to rabies virus, typically via bites, scratches, or mucosal contact from a potentially rabid animal. It is always administered in conjunction with rabies vaccine as part of the recommended rabies PEP regimen.\u003c\/p\u003e\n\u003ch3\u003eImportant: CDC Guidelines for Use\u003c\/h3\u003e\n\u003cp\u003eAccording to the \u003cstrong\u003eCenters for Disease Control and Prevention (CDC)\u003c\/strong\u003e guidelines:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRabies Immune Globulin (RIG)\u003c\/strong\u003e must be used in conjunction with rabies vaccine for previously unvaccinated individuals.\u003c\/li\u003e\n\u003cli\u003eRIG should be infiltrated around and into the wound site as soon as possible after exposure, followed by the rabies vaccine series.\u003c\/li\u003e\n\u003cli\u003eRIG should not be administered to persons who have been previously vaccinated against rabies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDosage and Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStandard Dose:\u003c\/strong\u003e 20 IU\/kg body weight (infiltrate as much as possible into and around the wound; any remaining should be injected intramuscularly at a site distant from vaccine administration).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparation:\u003c\/strong\u003e Each vial contains 1 mL of solution (300 IU\/mL).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute:\u003c\/strong\u003e Infiltration into wound(s) and\/or intramuscular injection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFrequency:\u003c\/strong\u003e Single administration at initiation of rabies PEP, \u003cstrong\u003enever after day 7\u003c\/strong\u003e of starting rabies vaccine, as it may interfere with the active immune response.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eDirections\u003c\/h4\u003e\n\u003col\u003e\n\u003cli\u003e\u003cstrong\u003eInitiate therapy immediately after exposure.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCalculate total volume required based on patient weight (20 IU\/kg).\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSlowly infiltrate as much of the total dose as anatomically feasible around the wound(s).\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdminister the remainder intramuscularly, distant from the rabies vaccine injection site.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eMechanism of Action\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHyperRAB\u003c\/strong\u003e contains concentrated antibodies (IgG) specifically active against the rabies virus. It provides immediate passive immunity by neutralizing the virus at the wound site and in tissues before the patient’s own immune response develops following vaccination.\u003c\/p\u003e\n\u003ch3\u003eProduct Details and Features\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNDC:\u003c\/strong\u003e 13533-0318-01\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Grifols Therapeutics\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSterile, preservative-free, single-use vial\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHigh concentration (300 IU\/mL) for efficient administration\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eReady-to-use liquid formulation\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eGamma globulin fraction of human plasma\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMaximum safety via donor screening, viral inactivation, and purification steps\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWarnings and Precautions\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Contraindicated in persons with known history of anaphylactic or severe systemic reaction to human immunoglobulin preparations.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eDo NOT inject intravenously.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eUse with caution in individuals with IgA deficiency.\u003c\/li\u003e\n\u003cli\u003eRisk of transmitting infectious agents, including viruses and theoretically prions, cannot be completely eliminated due to human plasma source.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not exceed the recommended dose\u003c\/strong\u003e—excessive immunoglobulin can interfere with the efficacy of active rabies vaccination.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSide Effects\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Adverse Reactions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eLocal reactions (pain, tenderness, erythema, bruising at injection site)\u003c\/li\u003e\n\u003cli\u003eSystemic symptoms (headache, malaise, low-grade fever, chills)\u003c\/li\u003e\n\u003cli\u003eAllergic reactions (urticaria, rash, rarely anaphylaxis)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eReport any severe or unusual reactions to your healthcare provider immediately.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003eStorage\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eStore at 2–8°C (36–46°F). Do not freeze. Protect from light.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003e\u003cstrong\u003eHyperRAB 1 mL (300 IU\/mL) by Grifols Therapeutics\u003c\/strong\u003e is your trusted solution for immediate immune protection following potential rabies exposure, fully compliant with CDC rabies post-exposure guidelines. Ensure proper administration for optimal results and minimized risk. Always consult your healthcare professional for individualized PEP regimens.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003e\u003cstrong\u003eOrder HyperRAB today for reliable, fast-acting rabies post-exposure prophylaxis!\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"Default Title","offer_id":52279651860848,"sku":"13533-0318-01","price":999.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/HyperRAB--human-rabies-immune-globulin.jpg?v=1747657318"},{"product_id":"adacel-vaccine-syringes-for-immunization-for-whooping-cough-pertussis-tetanus-diphtheria","title":"Tdap Vaccine, Adacel Vaccine Active Booster Immunization for Tetanus, Diphtheria \u0026 Pertussis **Refrigerated (RX)","description":"\u003ch1\u003eTdap Vaccine – Overview and Schedule\u003c\/h1\u003e\n\u003cp\u003eAdacel is a vaccine used as a booster to protect against tetanus, diphtheria, and pertussis (whooping cough). It is approved for adolescents and adults aged 10 to 64 years. For younger children, a different vaccine called DTaP is recommended.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDiseases prevented:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTetanus (T)\u003c\/strong\u003e: A serious bacterial infection characterized by painful muscle stiffness and spasms, often referred to as \"lockjaw.\"\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiphtheria (d)\u003c\/strong\u003e: A bacterial illness that produces a thick coating in the nose and throat, which can cause difficulty breathing, heart complications, and paralysis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePertussis (ap)\u003c\/strong\u003e: Commonly known as whooping cough, this highly contagious respiratory disease leads to intense coughing spells that can disrupt breathing, particularly in infants.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProtect yourself and your community with Adacel Vaccine (Tdap), the leading booster immunization for tetanus, diphtheria, and pertussis (whooping cough). Manufactured by Sanofi Pasteur—a global healthcare leader—Adacel is FDA approved and CDC recommended for teens, adults, and pregnant women to ensure lasting immunity against these three serious diseases.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTdap\u003c\/strong\u003e stands for \u003cstrong\u003eTetanus, reduced Diphtheria toxoid, and acellular Pertussis\u003c\/strong\u003e. It is a combination vaccine (known by brand names like Adacel® and Boostrix®) that boosts immunity to tetanus (“lockjaw”), diphtheria, and whooping cough (pertussis) in older children and adults. Tdap is given as a single 0.5 mL intramuscular dose (containing tetanus toxoid, reduced diphtheria toxoid, and pertussis antigens). It is \u003cstrong\u003enot used in young children\u003c\/strong\u003e: children under 7 years receive the pediatric DTaP series. Instead, Tdap is given once as a booster in late childhood\/adolescence and then in various adult situations.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren\/Adolescents:\u003c\/strong\u003e After completing the 5-dose DTaP series in early childhood, \u003cstrong\u003eCDC recommends one dose of Tdap at age 11–12 years\u003c\/strong\u003e. (This single Tdap then replaces the 10-year tetanus booster.) If a preteen or teenager never received Tdap or missed it, they should get a dose when feasible.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdults (≥19 years):\u003c\/strong\u003e Adults should have \u003cstrong\u003eat least one lifetime dose of Tdap\u003c\/strong\u003e in late adolescence or adulthood if not previously given. Thereafter, they receive tetanus boosters every 10 years – typically with \u003cstrong\u003eTd (tetanus-diphtheria) vaccine\u003c\/strong\u003e, although \u003cstrong\u003eone of the 10-year boosters may be a Tdap\u003c\/strong\u003e if pertussis protection is needed. (For example, most adults receive Tdap once and then Td every 10 years.) If an adult has a severe tetanus-prone wound and their last tetanus booster was ≥5 years ago, providers may give a booster (Td or Tdap) for wound management.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant Women:\u003c\/strong\u003e CDC \u003cstrong\u003erecommends one dose of Tdap during each pregnancy\u003c\/strong\u003e, regardless of prior Tdap history. The preferred timing is \u003cstrong\u003eweeks 27–36 of gestation\u003c\/strong\u003e (early third trimester) to maximize antibody transfer to the infant. (If Tdap was not given during pregnancy and the mother never had Tdap before, it should be given immediately postpartum.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCatch-Up \u0026amp; Special Situations:\u003c\/strong\u003e Persons ≥7 years who have never received a “pertussis-containing” booster (i.e. no adolescent Tdap) should get at least one Tdap dose. Health-care personnel and others in contact with infants are also advised to have up-to-date Tdap. After the initial Tdap dose, routine boosters every 10 years use Td (or Tdap once if not already used).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn summary, \u003cstrong\u003eone dose of Tdap\u003c\/strong\u003e is routine at age ~11–12 (and in each pregnancy), with tetanus\/diphtheria boosters every 10 years thereafter. Follow CDC\/ACIP schedules and local guidelines for catch-up scenarios.\u003c\/p\u003e\n\u003ch2\u003eCPT Coding for Tdap\u003c\/h2\u003e\n\u003cp\u003eWhen billing for a Tdap vaccination, use \u003cstrong\u003eCPT® code 90715\u003c\/strong\u003e. CPT 90715 describes “tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, for intramuscular use, for individuals 7 years or older”. (In contrast, CPT 90714 is the code for Td vaccine with no pertussis component.\u003c\/p\u003e\n\u003cp\u003eBecause CPT 90715 is a \u003cem\u003evaccine product code\u003c\/em\u003e, it must be reported along with an immunization \u003cstrong\u003eadministration code\u003c\/strong\u003e on the claim. For example, for an adult (no physician counseling), use \u003cstrong\u003e90471\u003c\/strong\u003e for the first injection (and 90472 for each additional simultaneous injection). (For patients ≤18 years with significant physician counseling (beyond routine), use 90460\/90461 instead.) Always pair 90715 with a diagnosis for immunization (typically Z23, “encounter for immunization”) or an appropriate injury code if given for wound prophylaxis.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey Points:\u003c\/strong\u003e Tdap (CPT 90715) is given once at 11–12 years (and during each pregnancy). Adults then get tetanus boosters (Td or Tdap) every 10 years. When coding, use 90715 for the vaccine dose (age ≥7) plus the proper administration code (e.g. 90471).\u003c\/p\u003e\n\u003ch3\u003eProduct Highlights \u0026amp; Top Health Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTriple Protection:\u003c\/strong\u003e Shields against tetanus, diphtheria, and pertussis (Tdap), reducing the risk of severe illness, complications, and transmission.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Developed by Sanofi Pasteur, renowned for vaccine safety, efficacy, and innovation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBooster Immunization:\u003c\/strong\u003e Essential for adolescents (11 years and up), adults, and pregnant women to boost waning immunity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCDC \u0026amp; FDA Approved:\u003c\/strong\u003e Part of the CDC recommended vaccine schedule for routine and catch-up immunization.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaternal Immunization:\u003c\/strong\u003e Safe, effective protection for pregnant women to safeguard newborns from pertussis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchool \u0026amp; Employment Requirements:\u003c\/strong\u003e Meets immunization regulations for colleges, schools, and healthcare workers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReady-to-Use:\u003c\/strong\u003e Convenient, single-dose intramuscular injection for fast, seamless administration in any healthcare setting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Related Terms for this Product:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAdacel Tdap vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTdap booster shot\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTetanus vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eDiphtheria vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eWhooping cough vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePertussis immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC recommended Tdap\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdult booster immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTdap vaccine for pregnant women\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTdap shot for adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSchool vaccine requirements\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTravel vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBest Tdap vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSanofi Pasteur vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFDA approved vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTdap schedule\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTdap for healthcare workers\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunity against tetanus\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent diphtheria and whooping cough\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePediatric and adolescent immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTdap vaccine safety\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eImmunization for college students\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWhat It Is Used For\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eAdacel (Tdap) Vaccine\u003c\/strong\u003e is indicated for active immunization as a single booster dose for the prevention of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTetanus\u003c\/strong\u003e (lockjaw)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiphtheria\u003c\/strong\u003e (a serious bacterial throat infection)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePertussis\u003c\/strong\u003e (whooping cough)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eTarget groups:\u003c\/strong\u003e Adolescents and adults (ages 10–64), as a booster dose following primary vaccination series or when immunity needs refreshing, especially those in contact with infants or at increased risk of exposure.\u003c\/p\u003e\n\u003ch2\u003eDetails and Features\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCombination Tdap vaccine:\u003c\/strong\u003e Protects against three major infectious diseases\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePre-filled 0.5 mL single-dose syringes:\u003c\/strong\u003e Ensures dosing accuracy, convenience, and infection control\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreservative-free formulation:\u003c\/strong\u003e Safe for a broader range of patients\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh immunogenicity:\u003c\/strong\u003e Demonstrated robust antibody responses for all components\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLatex-free syringes:\u003c\/strong\u003e Reduces risk for latex-allergic individuals\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSanofi Pasteur quality:\u003c\/strong\u003e Renowned leader in vaccine research and safety\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store refrigerated at 2° to 8°C (36° to 46°F). Do not freeze.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDosage\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecommended Dose:\u003c\/strong\u003e A single 0.5 mL intramuscular (IM) injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Preferably into the deltoid muscle of the upper arm\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBooster Interval:\u003c\/strong\u003e Adacel may be given as a booster dose every 10 years or as recommended by national immunization guidelines.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCDC Guidelines\u003c\/h2\u003e\n\u003cp\u003eThe CDC’s Advisory Committee on Immunization Practices (ACIP) recommends:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e1 dose of Tdap (Adacel or Boostrix)\u003c\/strong\u003e for adolescents (11-12 years) and adults who have not previously received Tdap\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnant women:\u003c\/strong\u003e 1 dose during every pregnancy (preferably at 27–36 weeks gestation)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBooster every 10 years\u003c\/strong\u003e with Td or Tdap for ongoing protection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmediate protection for close contacts of infants\u003c\/strong\u003e and healthcare providers\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eVaccination is essential for interrupting the transmission of pertussis to vulnerable infants and preventing outbreaks of tetanus and diphtheria.\u003c\/p\u003e\n\u003ch2\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp\u003eThe Adacel vaccine stimulates the immune system to produce specific antibodies against tetanus, diphtheria, and pertussis toxins and antigens. Upon exposure to these bacteria, the immune system recognizes and neutralizes them, preventing the development of disease or limiting its severity.\u003c\/p\u003e\n\u003ch2\u003eDirections\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eInspect vaccine:\u003c\/strong\u003e Ensure the product has not expired and check for particulate matter or discoloration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShake syringe:\u003c\/strong\u003e Gently shake until a uniform, cloudy suspension is observed.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrepare injection site:\u003c\/strong\u003e Cleanse with alcohol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdminister dose:\u003c\/strong\u003e Inject 0.5 mL intramuscularly, preferably into the deltoid muscle.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDispose safely:\u003c\/strong\u003e Sharply and immediately dispose of used syringe in an approved sharps container.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecord immunization:\u003c\/strong\u003e Update patient’s vaccination record.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2\u003eWarnings\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo NOT use in individuals:\u003c\/strong\u003e With a history of severe allergic reaction or anaphylaxis to any component, previous Tdap or other tetanus\/diphtheria-containing vaccines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePostpone vaccination:\u003c\/strong\u003e During moderate or severe acute illness (wait until recovery).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNot for use in children \u0026lt;10 years or adults 65+ years\u003c\/strong\u003e (prefer age-appropriate Td\/Tdap).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHistory of Guillain-Barré syndrome:\u003c\/strong\u003e within 6 weeks after a previous tetanus vaccine—use caution.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLatex allergy:\u003c\/strong\u003e Check product labeling (most Adacel syringes are latex-free).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosing errors:\u003c\/strong\u003e Do not mix with other vaccines in the same syringe.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSide Effects\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePain, redness, or swelling at injection site\u003c\/li\u003e\n\u003cli\u003eHeadache, fatigue\u003c\/li\u003e\n\u003cli\u003eMild fever, chills\u003c\/li\u003e\n\u003cli\u003eBody aches, soreness\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eLess Common but Serious Side Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSevere allergic reaction (anaphylaxis)\u003c\/li\u003e\n\u003cli\u003eNeurologic complications (extremely rare, e.g., Guillain-Barré syndrome, brachial neuritis)\u003c\/li\u003e\n\u003cli\u003eFainting (more common in adolescents—observe for 15 minutes after injection)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIf any severe reaction occurs, seek immediate medical attention.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003eProtect yourself and your community with Adacel Vaccine Syringes by Sanofi Pasteur—the safe and trusted choice for comprehensive Tdap booster immunization in adolescents and adults. Easy, convenient, preservative-free, and highly effective.\u003c\/span\u003e\u003c\/p\u003e","brand":"Sanofi Pasteur","offers":[{"title":"Syringes 0.5 ml (5 Pack)","offer_id":52319925076336,"sku":"49281-0400-20","price":379.0,"currency_code":"USD","in_stock":true},{"title":"Vials (Single-Dose 0.5 ml (10 pack)","offer_id":52319925109104,"sku":"49281-0400-10","price":775.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tdap-Vaccine-Adacel-Vaccine-Active-Booster-Immunization.jpg?v=1781102895"},{"product_id":"abrysvo-rsv-vaccine-respiratory-syncytial-virus-act-o-vial-0-5-ml-1-dose-pfizer-uspg","title":"Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) Pfizer USPG **Refrigerated (RX)","description":"\u003cp\u003eDefend against Respiratory Syncytial Virus (RSV) with the Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) by Pfizer USPG—the breakthrough, FDA-approved RSV vaccine for adults and maternal immunization. As recommended by the CDC, Abrysvo delivers advanced protection to high-risk populations, including adults 60+, pregnant women, and individuals with chronic health conditions.\u003c\/p\u003e\n\u003ch3\u003eProduct Highlights \u0026amp; Top Health Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComplete RSV Protection:\u003c\/strong\u003e Guards adults, seniors, and pregnant women against severe RSV infection, RSV pneumonia, and RSV-related bronchiolitis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-Dose Act-O-Vial:\u003c\/strong\u003e Convenient 0.5 mL intramuscular injection, ideal for clinics, hospitals, and healthcare providers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePfizer Quality:\u003c\/strong\u003e Developed by Pfizer USPG, a world leader in vaccines and infectious disease prevention.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA Approved \u0026amp; CDC Recommended:\u003c\/strong\u003e Robust clinical studies support its efficacy and safety for respiratory syncytial virus immunization.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaternal RSV Immunization:\u003c\/strong\u003e Protects newborns through passive immunity by vaccinating expectant mothers during pregnancy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSenior \u0026amp; High-Risk Vaccination:\u003c\/strong\u003e Designed for adults aged 60 and above, as well as those with underlying conditions such as heart or lung disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Hospitalizations:\u003c\/strong\u003e Minimizes the risk of hospital visits and severe outcomes due to RSV.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTop Health terms for this Product:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eAbrysvo RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine for adults\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccination for seniors\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRespiratory syncytial virus vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePfizer RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eFDA approved RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCDC recommended RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV vaccine side effects\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMaternal RSV immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBest RSV vaccine for pregnancy\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV shot for elderly\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePrevent RSV in infants\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eRSV immunization schedule\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSingle dose RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAct-O-Vial RSV vaccine\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eProtection from RSV pneumonia\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eVaccine for bronchiolitis prevention\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdult respiratory vaccines\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePregnancy vaccines for RSV\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHigh-risk respiratory immunization\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRSV is a leading cause of lower respiratory infections, pneumonia, and hospitalizations among adults 60 and older, people with chronic health conditions, and newborns via maternal transmission.\u003c\/strong\u003e The Abrysvo RSV Vaccine Act-O-Vial is formulated to deliver advanced, season-long protection. By choosing Abrysvo, you’re selecting:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCutting-edge RSV prevention\u003c\/strong\u003e for seniors, adults, and expecting mothers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaternal vaccine protection\u003c\/strong\u003e that safeguards both mother and baby from severe RSV.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConfidence in vaccination\u003c\/strong\u003e with Pfizer’s proven safety, quality, and worldwide trust.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAlignment with the latest CDC and FDA RSV vaccine guidelines\u003c\/strong\u003e for high-risk patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDirections for Use\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage Form:\u003c\/strong\u003e 0.5 mL Act-O-Vial, single intramuscular dose\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e Adults 60+, pregnant women for maternal antibody transfer, and other at-risk individuals as per CDC and FDA guidance\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e By healthcare professional in clinics, hospitals, or physician’s offices\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Refrigerate; do not freeze.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSafety \u0026amp; Side Effects\u003c\/h3\u003e\n\u003cp\u003eThe Abrysvo RSV vaccine is well-tolerated and extensively tested. The most common side effects include mild injection site pain, fatigue, headache, and slight swelling—serious reactions are exceedingly rare. Always consult your healthcare provider before vaccination, especially regarding allergies or prior vaccine reactions.\u003c\/p\u003e\n\u003ch3\u003eOrder Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) Today\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eStay protected this RSV season.\u003c\/strong\u003e The Abrysvo RSV Vaccine Act-O-Vial 0.5 mL (1 Dose) by Pfizer USPG is the leading choice for comprehensive RSV immunization in seniors, adults, high-risk groups, and pregnant women seeking to protect their infants. Make Abrysvo part of your immunization program and meet CDC vaccine requirements with confidence.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuy Abrysvo RSV Vaccine today for industry-leading, FDA-approved protection against the risks of RSV pneumonia, bronchiolitis, and respiratory complications. Trust Pfizer—the name in respiratory health.\u003c\/strong\u003e\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":52510764433776,"sku":"00069-2465-01","price":449.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Abrysvo-RSV-Vaccine-for-Respiratory-Syncytial-Virus-Act-O-Vial-Pfizer.jpg?v=1756387983"},{"product_id":"flu-vaccine-2025-2026-afluria-trivalent-influenza-vaccine-0-5-ml-x-10-syringes-rx","title":"Flu Vaccine 2025-2026 AFLURIA Trivalent Influenza Vaccine (Flu Shot) 0.5 mL x 10 Syringes (RX)","description":"\u003cp\u003e\u003cstrong\u003eBuy AFLURIA Trivalent Influenza Vaccine 2025-2026 | 0.5 mL x 10 Syringes by Seqirus | Flu Shot \u0026amp; Immunization\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProtect yourself, your family, and your patients this flu season with the most trusted flu vaccine: the AFLURIA Trivalent Influenza Vaccine 0.5 mL x 10 Syringes (2025-2026) by Seqirus. Specially designed for effective seasonal flu prevention, this trivalent flu vaccine offers optimal protection against the top circulating influenza virus strains anticipated for the 2025-2026 flu season.\u003c\/p\u003e\n\u003ch2\u003eWhy Choose AFLURIA Trivalent for Your Influenza Immunization?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLatest 2025-2026 Formulation:\u003c\/strong\u003e Updated by Seqirus to include WHO-recommended viral strains for broad-spectrum influenza protection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrivalent Advantage:\u003c\/strong\u003e Covers three major influenza virus strains.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh-Efficacy Flu Shot:\u003c\/strong\u003e Proven immunogenicity for adults and children—ideal for clinics, hospitals, schools, and community health settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReady-to-Use Syringes:\u003c\/strong\u003e Box includes 10 pre-filled 0.5 mL syringes for convenient, single-dose administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Manufacturer:\u003c\/strong\u003e Seqirus is a global leader in flu vaccine development and public health solutions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHealth Benefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevent Seasonal Flu:\u003c\/strong\u003e Significantly reduce risk of influenza-related hospitalizations, serious complications, and transmission.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecommended by CDC \u0026amp; WHO:\u003c\/strong\u003e Part of annual immunization campaigns for high-risk individuals, including elderly, children, healthcare workers, and those with chronic conditions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBoost Immunity:\u003c\/strong\u003e Helps maximize collective immunity and safeguard communities during flu season.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMinimal Side Effects:\u003c\/strong\u003e Mild, short-term side effects—such as soreness at injection site, mild fever, or fatigue—are rare and manageable.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContributes to Herd Immunity:\u003c\/strong\u003e Critical for public health, reducing the overall disease burden.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWho Should Get the AFLURIA Trivalent Flu Shot (2025-2026)?\u003c\/h2\u003e\n\u003cp\u003eIdeal for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdults (18 and older)\u003c\/li\u003e\n\u003cli\u003eChildren and adolescents (consult with healthcare provider)\u003c\/li\u003e\n\u003cli\u003eSeniors \u0026amp; individuals with chronic health conditions\u003c\/li\u003e\n\u003cli\u003ePregnant women (safe with healthcare consultation)\u003c\/li\u003e\n\u003cli\u003eHealthcare workers \u0026amp; essential personnel\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eHow to Use\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Refrigerate between 2°C and 8°C. Do not freeze.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Inject 1 pre-filled 0.5 mL syringe intramuscularly, as per CDC guidelines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSchedule:\u003c\/strong\u003e Ideally administered annually before the onset of flu season.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2\u003eTrusted by Healthcare Professionals Worldwide\u003c\/h2\u003e\n\u003cp\u003eEach batch of the AFLURIA Trivalent Influenza Vaccine undergoes rigorous quality testing and adheres to strict safety standards. With millions of doses administered yearly, Seqirus stands at the forefront of flu prevention, protecting families and communities globally.\u003c\/p\u003e","brand":"Seqirus","offers":[{"title":"Default Title","offer_id":52745702769008,"sku":"33332-0025-03","price":265.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Flu-Vaccine-2025-2026.jpg?v=1764864299"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/collections\/RSV-Vaccines.jpg?v=1775749278","url":"https:\/\/www.mountainside-medical.com\/collections\/vaccines\/merck+pneumococcal.oembed","provider":"Mountainside Medical","version":"1.0","type":"link"}